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i. Abbreviations
BDNF brain derived neurotrophic factor
BZD benzodiazepine
CCC cation-chloride cotransporters
CCI chronic constriction injury
CFA Complete Freud’s Adjuvant
CGRP calcitonin gene-related peptide
CNS central nerve system
COX-2 cyclooxygenase-2
CUP Ca2+ uni-porter
DRG dorsal root ganglion
DRR dorsal root reflex
DZP diazepam
ER endoplasmic reticulum
FRET Fluorescence resonance energy transfer
GABA gamma-Aminobutyric acid
GAD glutamic acid decarboxylase
GAT1 GABA transporter 1
GCT gate control theory
GDNF neurotrophic factor
GECI genetically encoded calcium indicator
GlyR3 glycine receptor 3
IASP International Association for the Study of Pain
IB4 isolectin B4
KCC2 K-Cl co-transporter 2
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NCX Na+/Ca2+ exchanger
NGF nerve growth factor
NKCC1 Na-K-2Cl co-transporter
PAD primary afferent depolarization
PBS phosphate-buffered saline
PFA paraformaldehyde
PGE2 prostaglandin E2
PKA protein kinase A
PMCA plasma membrane Ca2+-ATPase
PNS peripheral nerve system
ROI region of interest
SC spinal cord
SERCA Ca2+-ATPase
TrkA tyrosine receptor kinase A
TrkB tyrosine receptor kinase B
TRPV1 transient receptor potential vanilloid subfamily type 1
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1 Abstract
GABAergic inhibition modulates nociceptive signal transmission in spinal cord via af-
fecting both presynaptic and postsynaptic elements. Damage to nerve and/or tissue (in-
flammation) often disrupts this regulation and causes pathological pain. The inhibition
of  postsynaptic  spinal  neurons had been intensively studied, while the inhibition of
presynaptic terminals of peripheral sensory neurons was less focused due to the techni-
cal difficulty. 
I generated transgenic mice, which specifically express GCaMP3, a genetically encoded
calcium indicator, in nociceptors (SNS-Ai38) or all-sensory neurons (advillin-Ai38), to
investigate the GABAergic presynaptic inhibition in spinal cord. GABA showed signifi-
cant  inhibitory  effect  on presynaptic  nociceptor  central  terminals  from intact  mice.
However, peripheral nerve injury and inflammation almost completely abolished this
inhibition,  mainly  due  to  the  NKCC1-dependent  upregulation  of  intracellular  [Cl-].
Moreover, inflammation could facilitate GABAergic excitatory effect, which was only
observed in spinal cord from SNS-Ai38 but not from advillin-Ai38. The Nociceptor-
specific  and  all-sensory  specific  GABAA  receptor  knockout  mice  (SNS-β3-/- and
advillin-β3-/-) were generated to examine the function of presynaptic inhibition in vivo.
Both SNS-β3-/- and advillin-β3-/- were more sensitive to thermal and mechanical stimuli
compare to their wild type litter mates (β3fl/fl). Yet difference between these two condi-
tional knockout line was observed. Inflammation could not further the mechanical allo-
dynia in SNS-β3-/- to the same level as it did in their β3fl/fl litter mates. Such difference
was not observed in advillin-β3-/- mice and their litter mates. The difference between
results from SNS-Cre and advillin-Cre generated transgenic mice after inflammation
most likely was caused by their different Cre recombinase expression patter in pep-
tidergic nociceptors according to immunohistochemistry study. This implies that part
of peptidergic nociceptors are crucial for inflammation induced mechanical allodynia. 
Overall, our data reveal that GABAergic presynaptic inhibition modulates thermal and
mechanical spinal nociceptive processing. Nerve injury and peripheral inflammation
can both result  in nociceptor [Cl-]  elevation and disturb the presynaptic  regulation.
Furthermore,  the malfunctioning presynaptic  control  caused by them contributes  to
pain modalities differently. 
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2 Introduction
2.1 Acute and pathological pain
International Association for the Study of Pain (IASP) defines pain as “an unpleasant
sensory and emotional experience associated with actual or potential tissue damage, or
described in terms of such damage”1. In healthy subjects, acute pain is generated by
noxious stimuli applied to receptive field of nociceptors. In pathological state, pain feel-
ing maybe more intensive when noxious stimuli  is  applied (hyperalgesia),  and pain
could be induced by non-noxious stimuli (allodynia) or even without any stimuli (spon-
taneous pain).
One major group of pathological pain is chronic pain, which had been estimated to af-
fect one-sixth of the population2. Chronic pain, not like the protective and adaptive pain
in common condition, does not carry any useful purpose. Approximately 20% of the
adult  European population33 and at  least  116 million US adults  suffer  from chronic
pain4in both the physical and emotional way. The current annual cost in society is esti-
mated more than €200 billion in Europe and $150 billion in USA3. However, 79 % suf-
ferer still have chronic pain after treatment5. According to etiology,  peripheral nerve
system (PNS) originated  chronic pain can be divided into 2 subgroups,  neuropathic
pain and inflammatory pain. Neuropathic pain is caused by a lesion or disease of the
somatosensory nervous system1. Chronic inflammatory pain, on the other hand, is gen-
erated by lesion of non-neural tissue and the following inflammatory factors release. 
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2.2 Peripheral sensory neurons related to 
nociception
2.2.1 Properties of sensory neurons
Primary sensory neurons in somatosensory system are cells that sense the external or
internal state of body, then encode the information into electrical signal and transmit it
to spinal cord (SC). They are pseudo-bipolar neurons, which have their cell soma sit in
ganglia in spine, projecting one branch of axon to periphery to sense stimuli, and an-
other to spinal cord or brain stem to relay the encoded signal to central nervous system.
Primary sensory neurons  are  highly  specialized.  Various cutaneous stimuli,  such as
gentle  touch,  temperature,  pinch etc,  are  conveyed  by  different  sensory  fibers.  The
thickest myelinated Aβ fiber neurons have a low mechanical threshold and respond to
innocuous tactile stimulus. And the majority of thin myelinated Aδ fiber and unmyeli-
nated C fiber neurons are nociceptors or thermoreceptors. Due to the fact that most Aδ
and C fiber neurons are smaller than Aβ fiber neurons, size is commonly used to sepa-
rate nociceptors from non-nociceptors. In mice, dorsal root ganglion (DRG) neurons
can be generally classified into small  (diameter < 25  μm, putative nociceptors) and
large (diameter >= 25 μm, putative non-nociceptors).
2.2.2 Nociceptors classification based on molecular markers
Nociceptors can be further subdivided into peptidergic and non-peptidergic neurons.
Peptidergic neurons are recognized by their expression of peptides, such as substance P
and calcitonin gene-related peptide (CGRP).  They require nerve growth factor (NGF)
binding to their tyrosine receptor kinase A (TrkA) for development6. Capsaicin recep-
tor, transient receptor potential vanilloid subfamily type 1 (TRPV1), is also expressed by
many of these neurons7,8. Non-peptidergic nociceptors, on the other hand, switch their
NGF-TrkA dependency to glial cell line-derived neurotrophic factor (GDNF)/Ret as an-
imal matures6, and are characterized by their binding of plant lectin isolectin B4 (IB4).
Although peptidergic and non-peptidergic neurons are commonly used term to divide
nociceptors, a notable overlapping of these 2 subpopulations had been reported by sev-
eral studies9–12.
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2.3 Spinal cord anatomy related to nociception
The anatomy of spinal cord dorsal was thoroughly studied, and its neuronal compo-
nents had been well reviewed13,14. The gray matter in spinal cord is divided into 10 lami-
nae (I – X) from dorsal horn to ventral horn according to functionally distinct popula-
tions of neurons (Figure 1). Cutaneous sensory input is relayed into dorsal horn lami-
nae including number I – V. Lamina I, which is composed of projection neurons and in-
terneurons, is a thin layer located in the most superficial part of dorsal horn gray mat-
ter. It receives input from small myelinated Aδ fiber and unmyelinated C fiber. Multiple
modalities signal such as warm, cold, itch, and pain is transmitted into this layer. Pep-
tidergic nociceptors mainly target lamina I and therefore CGRP and substance P are
usually used to mark this layer. Inhibitory and excitatory interneurons highly populate
in laminae II and III. They receive information from primary afferents and finally pass
it to projection neurons lie in Laminae I, IV and V. Although these interneurons also
make connections to each other, and this network is believed to be important for input
processing, the exact circuits for different modality inputs are still under investigated
due to technical difficulty. Non-peptidergic nociceptors mainly send input into lamina
II, thus, IB4 is commonly used to label this layer. The deeper layers of dorsal horn in-
cluding laminae III, IV and V are the main targets of myelinated Aβ fiber, which trans-
mit non-noxious tactile stimulus.
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2.4 Spinal cord circuit gating nociception
2.4.1 Gate control theory. 
Melzack and Wall published their Gate Control Theory (GCT) half century ago15 (Fig-
ure 2). GCT suggests pain signal generation and transmission does not solely depend
on pain specific pathway or is simply different from non-painful signal on magnitude
described in previous published theories. It hypothesizes that a circuit lying in spinal
cord dorsal horn, where signals from nociceptive and non-nociceptive afferents con-
verge via interneurons, is able to dynamically modify the pain signal flow from PNS to
central nerve system (CNS) like opening and closing a gate. When signal transmitted in
large-diameter  (non-nociceptive)  afferents  activates  inhibitory  interneurons,  input
from small-diameter  (nociceptive)  afferents  to  projection  neurons  is  suppressed  by
these interneurons. In other words, the gate is closed. However, noxious stimuli gener-
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Figure 1: Spinal cord laminar organization and primary afferents innervation. Spinal cord gray
matter  is divided into 10 parallel  laminae according to variations in the size and density of
neurons. (a) Rat spinal cord section stained with NeuN antibody labeling neurons. Lamina I and
Lamina II (also known as substantia gelatinosa) form superficial layer. Lamina II can be further
divide into outer (IIo) and inner (IIi) layers. (b) The innervation pattern of primary afferents is well
organized. Spinal dorsal horn (Laminae I – V) receive input from primary afferents. Deep layers,
laminae III – V, of dorsal horn are innervated by Aβ fibers transmitting non-nociceptive signal.
Aδ fibers end mainly in superficial layers with some extension into lamina III. Peptidergic fibers
arborize within lamina I and IIo layers. Non-peptidergic fibers end in lamina II layer. (From Todd,
201014)
ated activity in small-diameter afferents can turn the key to the opposite direction by
inhibiting interneurons firing, and thus open the gate. In addition to external stimuli,
descending input from brain is also applied to this circuit, which explains the role of
emotion state on pain perceptive.  
The critical component of GCT, inhibitory interneurons, were merely speculative cells
when Melzack and Wall published their theory. Following studies proved the existence
of these neurons in spinal dorsal horn with immunochemistry and electrophysiology16–
18. Furthermore, Bohlhalter et at.19 have displayed the distribution pattern of GABAA re-
ceptor in rodent spinal cord dorsal horn in detail. These studies showed evidence sup-
porting GCT interneuron concept on cellular and molecular level.  
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Figure  2: Gate control theory (GCT). The original idea introduced a neuronal circuit in spinal
dorsal horn consisting of primary afferents (L, large diameter putative non-nociceptors; S, small
diameter putative nociceptors), projection/transmission (T) cells, lamina II (substantia gelatinosa
[SG])  interneurons,  and  supraspinal  central  control.  The  core  element  of  GCT  is  SG
interneurons which regulate signal transmission from large and small diameter primary afferents
to T cells with presynaptic and postsynaptic connections. Non-nociceptive signal activates large
diameter fibers, and in turn activates interneurons which inhibit signal transmission to T cells,
i.e.  closing the gate.  Small  diameter fibers can open the gate by inhibiting the output  from
interneurons. The successful delivery of signal to T cells depends on the balance between the
input from large and small diameter fibers. (From Braz et al., 201413)  
2.4.2 Spinal GABA inhibition 
gama Aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the PNS
as well as in the CNS. It is released from GABAergic neurons and binds to both of chlo-
ride permeable GABAA receptors and GABAB receptors, which are G protein coupled re-
ceptors. GABAA receptors mediate principal effect of GABA by increasing membrane
permeability to chloride. 
Mammalian GABAA receptors are ligand-gated chloride channels comprised of 5 sub-
units out of 19, including α1-6, β1-3, γ1-3, δ, ε, θ, π, and ρ1-3 (Figure 3). In spite of the
large diversity of isoforms, the majority of GABAA receptors contain two α subunits, two
β subunits, and one γ subunit (Figure 4).  They commonly have two GABA binding
sites located at α/β subunit interface, and one bensodiazepine (an exogenous modula-
tor) site located at α/γ subunit interface20.The expression pattern of GABAA receptor
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Figure 3: Dendrogram of 19 genes coding human GABAA receptor subunits. (From Sigel
et al., 201220)
subunits  have  been  mainly  studied  on  mRNA  level  and  protein  level  in  rats  and
mice19,21. In these studies, α3, β2/3, and γ2 subunits exhibited widespread expression in
the whole dorsal horn, and α1, α2 and α5 subunits were found to be expressed in multi-
ple laminae,  but distribute differently.  Staining for α1 and α5 subunits appeared in
laminae II-V, but was absent in lamina I. α2 subunits staining could be found in the
whole dorsal horn, but most prominent in superficial layer laminae I and II. These sub-
units were suggested to be expressed on both spinal neurons and primary afferent ter-
minals19,21.
In rat spinal cord dorsal horn, ~25%, 30% and 40% neurons are GABAergic in lamina I,
lamina II and lamina III respectively22.  These GABAergic interneurons have various
morphology and express  diverse chemical  markers13,14.  Dual patch clamp recordings
suggest GABAergic interneurons receive input from primary afferents23. Further, previ-
ous anatomical  studies  have revealed that  GABAergic interneurons make contact  to
projection neurons14. However, the patterns of signal flow in the circuit composed of
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Figure 4: Schematic structure of GABAA receptor. (a) membrane topology of a single subunit.
(b) Top view of a GABAA receptor subtype, α1β2γ2, with 2 GABA binding site between α and
β subunits, and a bensodiazepine between a and γ subunits. The sidedness of the subunits is
symbolized + and -. (From Sigel et al., 201220)
primary afferents, interneurons (inhibitory and excitatory) and projection neurons are
far from clear.
Intrathecal injection of GABA or positive allosteric GABAA receptor modulator benzodi-
azepine  (BZD),  such  as diazepam  (DZP),  shows  anti-nociceptive  effect  and  rescues
nerve injury induced chronic pain via enhancing spinal GABAergic inhibition24–28. Pro-
hibiting  GABAergic  inhibition  exhibits  opposite  effect,  i.e.  increasing  pain  behavior
when nociceptive stimuli applied (hyperalgesia) or even generating pain behavior with
only non-nociceptive stimuli applied (allodynia)24,29–33. These pharmacological and be-
havior  studies  suggested a spinal  inhibition in  pain perception regulation,  which is
most possibly carried by GABAergic interneurons. 
2.4.3 Postsynaptic inhibition
Original GCT only proposes pre-synaptic inhibition for gating information flow, yet the
postsynaptic regulation on projection neuron is not excluded. In fact, the information
flows  from  primary  afferents  to  interneurons,  and  finally  to  projections  had  been
proved13,14,28. 
The effect of GABAA receptor activation depends on intracellular chloride concentra-
tion. If the intracellular [Cl-] is high enough to cause the reversal potential of chloride
(ECl) positive to neuron’s membrane potential (Vm), the opening of chloride permeable
pore in GABAA receptor results in chloride efflux, which consequently depolarizes the
neuron. If the [Cl-] is so low that the ECl is negative to neuron’s Vm, activation of  GABAA
receptor causes hyperpolarization of the neuron due to the chloride ion influx. The [Cl -]
is  mainly  regulated by various cation-chloride cotransporters  (CCC).  In mammalian
neurons,  the  accumulation of  chloride is  mainly  driven by Na-K-2Cl  co-transporter
(NKCC1), and the extrusion is largely mediated by K-Cl co-transporter 2 (KCC2). In
CNS, neurons have high NKCC1 expression but very low KCC2 expression during devel-
opment34. However, in mature animal, accompanied with downregulation of NKCC1,
the increase of KCC2 reduces the [Cl-], and thus hyperpolarizes the Ecl, which is low
enough to generate chloride influx when GABAA receptor is open34. In intact mature an-
imal, the postsynaptic neurons, i.e. CNS neurons in spinal dorsal horn, are inhibited by
GABA with this mechanism. 
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2.4.4 Pre-synaptic inhibition
Compare to the postsynaptic inhibition, the story of pre-synaptic side, primary affer-
ents,  is  different.  Unlike  CNS neurons,  DRG neurons  keep high expression level  of
NKCC1 in adults, while KCC2 is expressed at very low level or even absent35–38. There-
fore, DRG neurons in adults maintain a high intracellular chloride concentration which
cause the reversal potential of chloride (ECl) more depolarized than resting membrane
potential39. Consequently, when GABA binding opens central pore of GABAA receptor,
the outflow of  chloride induces depolarization rather  than hyperpolarization.  It  has
been decades that GABA is considered to be the important transmitter to induce presy-
naptic inhibition via generating primary afferent depolarization (PAD), which reduces
excitatory transmitter release from primary afferent central terminal40. Several mecha-
nisms had been proposed to explain the inhibitory effect of PAD41. Depolarization on
nociceptor central terminals may cause inactivation of voltage-gated calcium channels,
and thus reduces calcium influx and transmitter release. Voltage-gated sodium chan-
nels may also be inactivated by PAD, together with shunting effect by opening GABAA
receptor, propagation of action potential towards primary afferents terminal could be
hampered.
2.5 Alterations of inhibitory synaptic 
transmission in pathological states
Pain perception is not generated by a plain signal relay induced by noxious stimuli, but
a redundant and dynamic system, in which the transmission of noxious stimuli gener-
ated signal is regulated by both internal (from brain) and external (from non-noxious
and/or noxious stimuli)  input via multiple pathways involving various types of cell.
Malfunctioning component(s) may break the balance in this system and interrupt cod-
ing of somatosensory stimuli, thus causing pathological pain, such as hyperalgesia and
allodynia28,42–44. Previous studies showed intrathecal injection of GABAA receptor antag-
onist, bicuculline, resulted a dose-dependent allodynia and hyperalgesia45,46. Further,
Baba  et  al.  reported that  bicuculline  effectively  facilitated primary afferents  evoked
polysynaptic EPSCs in lamina II neurons47. And this effect of bicuculline was dramati-
cally diminished after nerve injury and inflammation47,48. Another study observed pri-
mary afferents evoked IPSCs in lamina II neurons was reduced after various types of
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nerve injury, and GABAA receptor-mediated IPSCs was decreased as well49. These evi-
dence suggests GABAA receptors dependent inhibition in spinal dorsal horn is altered
by nerve injury and this may contribute to allodynia and hyperalgesia caused by nerve
injury and inflammation.    
2.5.1 Change of postsynaptic inhibition
Because GABAA receptors mediated inhibition has different mechanisms for presynap-
tic central terminals and postsynaptic spinal neurons. The alterations caused by nerve
injury and/or inflammation may also differ. For spinal neurons, Coull et al. reported
that [Cl-] in lamina I neurons was elevated due to the reduction of KCC2 after nerve in-
jury,  and the  subsequently  shifted  reversal  potential  of  chloride  greatly  diminished
GABAergic inhibitory controls or even switch it to exciatation50. The same group after-
wards revealed the role of microglia in this change of postsynaptic inhibition51. In brief,
after nerve injury, microglias release brain derived neurotrophic factor (BDNF) upon
the stimulation of ATP, the binding of BDNF on lamina I neurons tyrosine receptor ki-
nase B (TrkB) receptors causes downregulation of KCC2 and the following [Cl-] eleva-
tion51 (Figure 5).
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2.5.2 Change of presynaptic inhibition
Due to the technical difficulty, the physiological recording of presynaptic inhibition and
its change in pathological condition were mainly studied by recording the central stump
of a cut filament of a dorsal root. Willis had reviewed that when PAD reached firing
threshold, it could generate a back-traveled action potential from primary afferent ter-
minal to peripheral side, which was named as dorsal root reflex (DRR)52. DRRs were re-
ported to increase after inflammation, and increased DRRs caused release of neuro-
transmitters  which  generated  neurogenic  inflammation  on  peripheral  side  and  in-
creased excitability of postsynaptic neurons on central side52. Possible reasons for the
increase in DRRs might be the upregulation of GABAergic system in spinal dorsal horn
or the activity increase of NKCC1, both of which may intensify the chloride outflow gen-
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Figure  5:  Postsynaptic  change in  neuropathic  pain.  Peripheral  nerve  injury  activates  spinal
microglia via ATP and/or chemokine ligand 2 (CCL2). The activated microglia release BDNF,
which binds to TrkB receptors on lamina I neurons. BDNF-TrkB signaling downregulate chloride
co-transporter KCC2, which causes the rise of intracellular [Cl-] in lamina I neurons. This [Cl-]
change disrupts the GABAA receptor mediated postsynaptic inhibition, which generates inward
flow of Cl- and hyperpolarizes the postsynaptic neurons in physiological condition. (From Braz et
al., 201413)  
erated membrane depolarization. Funk et al. reported an upregulation of  intracellular
[Cl-] of DRG neurons, which might be contributed by enhanced NKCC1 activity, after
inflammatory mediators treatment53. However, whether pathological conditions, such
as nerve injury and peripheral inflammation, has the similar impact on DRG neuron
[Cl-] remains unclear. In addition, the influence of the elevated intracellular [Cl -] on the
physiological function of presynaptic terminals has not been discovered yet.
2.6 Objectives
DRG neurons respond to cutaneous stimulation and convey the information to central
nervous system in spinal dorsal horn. This input information is then processed by post-
synaptic interneurons and projection neurons there. Studies had confirmed GABAergic
spinal  inhibition,  and  the  function  of  postsynaptic  inhibition  in  physiological  and
pathological  conditions had been well  characterized.  However,  the presynaptic  side,
central terminals of primary afferents, was less focused due to the technical difficulty.
Electrophysiological technique such as patch clamp is commonly used to study neuron
activity. The function of GABA on spinal dorsal horn neurons were well investigated
with this method. Unfortunately, it can not be applied on presynapses. Besides, calcium
imaging, which is another frequently used technique for live cell study, were prevented
from recording presynapse-only signals due to the difficulty of mass labeling central
terminals in acute spinal cord slices. Cre-Lox recombination makes it possible to specif-
ically express genetically encoded calcium indicator (GECI) in sensory neurons with
proper transgenic mouse lines, thus allowing calcium recording on central terminals of
primary afferents. 
The objective of this project includes: (1) Generating conditional GECI expressing mice
and use them to examine the proposed GABAergic presynaptic inhibition; (2) Investi-
gating whether the proposed presynaptic inhibition is affected by nerve injury and pe-
ripheral inflammation.
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3 Methods
3.1 Animal
Experiments were carried out in adult C57BL/6 and several lines of transgenic mice
(male, aged 6-12 weeks, 20-25g in weight). Mice were housed 2 to 5 per cage, and main-
tained in a temperature and humidity-controlled room on a 12/12h light/dark cycle
with access to rodent chow and water ad libitum. All experiments were conducted ac-
cording to the guidelines of German Animal Protection Law.
3.1.1 Transgenic mice
Transgenic mice expressing Clomeleon54, a ratiometric Cl- indicator, under the control
of the Thy1 promoter were used for chloride imaging.
Two Cre mice lines were used for the study.  Cre recombinase is expressed under the
regulatory  elements  of  mouse  Scn10a gene,  and  of  mouse  advillin gene  in  SNS-
Cre55 and advillin-Cre56 mice lines respectively. The former transgenic mice line is from
the group of Dr. Kuner, and the latter is from the group of Dr. Heppenstall.  Scn10a
gene encodes the tetrodotoxin-resistant Nav1.8 sodium channel which is  mainly ex-
pressed  nociceptors57,  while  advillin gene  encodes  the  homonymous  actin
regulatory/binding protein restrictedly expressed in DRG neurons and superior cervi-
cal ganglia neurons58–60.
Ai38 (#014538) and Gabrb3-loxP mice (B6;129-Gabrb3tm2.1Geh1Geh/J, #008310) are from
the Jackson Laboratory. In Ai38 mice, a loxP-flanked STOP cassette prevents transcrip-
tion of the downstream GCaMP3 fusion gene until exposed to Cre recombinase. Off-
spring of Ai38 and Cre mice will have STOP cassette deleted in Cre expressing tissue,
and express calcium indicator protein, GCaMP3, which has low EGFP fluorescence in
the absence of calcium, and brighter fluorescence when binded by calcium. Gabrb3-
loxP mice possess loxP sites on either side of exon 3 of gene encoding GABAA receptor
β3 subunit. When Gabrb3-loxP mice are bred to Cre expressing mice, Offspring will
have exon 3 deleted in Cre-expressing cells.
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SNS-Ai38 and advillin-Ai38 were generated by breeding SNS-Cre mice and advillin-Cre
mice to Ai38 mice  respectively.  SNS-β3-/- and advillin-β3-/- mice  were  generated by
breeding SNS-Cre mice and advillin-Cre mice to Gabrb3-loxP mice respectively.
Mouse genotype was verified by PCR using primers as follows: SNS-cre Forward: 5’-
GAA AGC AGC CAT GTC CAA TTT ACT GAC CGT AC-3’; Reverse: 5’-GCG CGC CTG
AAG ATA TAG AAG A-3’. Advillin-cre Forward: 5’- GCA CTG ATT TCG ACC AGG TT-
3’; Reverse: 5’-GAG TCA TCC TTA GCG CCG TA-3’. Ai38 Mutant Forward: 5’-CTT CAA
GAT CCG CCA CAA CAT CG-3’; Mutant Reverse: 5’-TTG AAG AAG ATG GTG CGC TCC
TG-3’. Ai38 Wild type Forward: 5’-CCA AAG TCG CTC TGA GTT GTT ATC-3’; Wild
type Reverse: 5’-GAG CGG GAG AAA TGG ATA TG-3’.  Gabrb3-loxP Forward: 5’-
ATT CGC CTG AGA CCC GAC T-3’; Reverse: 5’-GTT CAT CCC CAC GCA GAC-3’.
3.2 Induction of chronic pain
Chronic constriction injury (CCI)61 was used to induce neuropathic pain in mice. In
brief, animal was deeply anesthetized with 2 % isoflurane (CP-Pharma, Germany). Skin
incision was made on one side after hair shaved. Sciatic nerve at the level of the right
mid-thigh was exposed by tearing connective tissue between the gluteus superficialis
and biceps femoris muscles. Four loose silk ligatures (4/0) were placed (with ~0.5 mm
spacing) around the sciatic nerve. Ligatures were tied until they elicited a brief twitch in
the respective hind limb62. The wound was closed with sutures in the muscle and sta-
ples in the skin. 
Inflammatory pain in mice was induced by intradermal injection of Complete Freud’s
Adjuvant (CFA), which consists of inactive Mycobacterium tuberculosis in mineral oil.
Animal was deeply anesthetized with 2 % isoflurane. Syringe with 25 gauge needle was
inserted approximately 2 mm, bevel up, into the metatarsal region of hindpaw and 20
μl CFA was slowly delivered. Needle was held still for 10 s to keep pressure before with-
drawing (adapted from Fehrenbacher et al.63). 
Animal used for CCI or CFA injection were placed back to cage after surgery and al-
lowed to recover for at least 24 h before any behavior test.    
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3.3 Behavior
Animal underwent CCI or CFA injection were examined by behavior test to verify the
effect of injury or inflammation. Animal were habituated on behavior test setups for at
lease 30 min 1 day prior to baseline tests, which were performed before surgery. 2-day
later, same tests were applied again and the effect of surgery was evaluated by compar-
ing these results with baseline data. All tests were taken in the morning. Mechanical
sensitivity was measured with von Frey hairs from 0.008 to 1.4 g (0.008, 0.02, 0.04,
0.07, 0.16, 0.4, 0.6, 1, and 1.4 g)64. Animal were placed in transparent plastic box sitting
on a metal mesh. The setup allows experimenter to observe animal behavior while ap-
plying mechanical stimulation with von Frey hair. The hair was lifted perpendicular to
the mid-plantar surface of hind paw until slightly bended, and held for about 6 s. A
quick withdraw of stimulated hind paw or immediate flinching upon removal of the
hair were considered a positive response. Other cases, such as slow withdraw, animal
walking away etc, required a repeat test. 5 tests were applied with each hair with a in-
terval of at least 5 s (adapted from Chaplan et al.64).
Plantar test with hargreaves apparatus (ugo basile, Italy) was employed to examine the
sensitivity of animal to thermal stimulation. Animal were placed in the same type of
plastic box used for von Frey test, but on glass pane instead of metal mesh. A movable
infrared generator with the intensity of 270±10 mW/cm2 under the glass pane applied
infrared heat stimulus and measured hind paw withdraw latency automatically. 3 or 4
measurement were taken for each animal with an interval of 5 min to avoid repeated
heat stimulation generated.
3.4 Cell culture
Mouse L4 and L5 DRGs were dissected and collected in-ice cold phosphate-buffered
saline (PBS). DRGs were washed once with PBS prior to incubation with 2 different en-
zymes,  collagenase and trypsin  which were used to  dissociate  DRG cells  from each
other. DRGs were first treated with 1 ug/ml collagenase type IV (Sigma, Germany) in 1
ml of PBS at 37 °C for 40 min. The supernatant was removed, and DRGs were incu-
bated with 1 ml of 0.05 % trypsin (Sigma, Germany) in PBS for another 30 min. The su-
pernatant was removed and DRG medium consisting of DMEM/Hams-F-12, 8 mg ml-1
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glucose, 100 U ml-1 penicillin, 100 µg mg-1 streptomycin, and 10% heat inactivated horse
serum, was added. DRGs were gently dissociated with pipette to obtain single cell sus-
pension and centrifuged  at 800 RPM for 5 min. The supernatant was removed, and the
cells were resuspended in DRG medium and seeded on poly-lysine (500 µg ml -1, at 37
°C for 18 h) and laminin (20 µg ml-1, at 37 °C for 1 h) coated coverslips. After 3-4 h, ad-
ditional DRG medium was added to cells. Cells were cultured for 12-24 h at 37 °C in in-
cubator. 
3.5 Acute spinal cord slice
Animal was deeply anesthetized with ketamin : xylazine : saline (1.5 : 0.75 : 7.75). The
total volume of anesthetic is 1% of animal weight. The anesthetic was delivered by in-
tra-peritoneal injection in 3 divided doses at 5 min interval. ½ of the total volume was
administrated for the first dose, ¼ of total volume was administrated for the second
and third doses. Animal back was shaved, and skin incision was made along lumbar
vertebrae. Spinal laminectomy was applied to expose lumbosacral spinal cord inner-
vated by L4 and L5 spinal nerve. This part of spinal cord was isolated after pia mater
removed,  and  placed  in  cold  Prep-Ringer  solution  (2–4  °C;  87mM  NaCl,  1.25mM
NaH2PO4, 25mMNaHCO3, 2.5mM KCl, 7mM MgCl2, 0.5mM CaCl2, 25mM glucose,
75mM sucrose). Next, it was embedded in 2% low melting agarose (Bio-Rad Laborato-
ried, CA 94547). A 300 μm transverse slice was cut from the embedded spinal cord on a
vibrating blade microtome (Leica VT1200, Leica, Germany). The spinal cord slice was
stored on a cellulose nitrate filter (Sartorius Stedim Biotech GmbH, Germany) perfused
with Ringer solution saturated with 95% O2 and 5% CO2 at room temperature follow-
ing 45–60 min perfusion at 33–34 °C for slice recovery.
3.6 Chloride imaging
Clomeleon is a fusion protein consisting of Cl- insensitive CFP and Cl- sensitive YFP65.
Fluorescence resonance energy transfer (FRET) occurs between two fluorophores due
to close spatial  proximity.  Quenching of YFP by Cl- causes the ratio of fluorescence
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emission to change in response to [Cl-]66. Thus, Clomeleon can be used as a ratiometric
indicator for Cl-. 
L4 and L5 DRG were removed from clomeleon mice and stored in oxygenized Ringer's
solution (124 mM NaCl, 1.25 mM NaH2PO4, 26 mM NaHCO3, 3 mM KCl, 2 mM MgCl2,
2  mM CaCl2,  10  mM glucose)  at  room temperature.  A  commercial  2-photon setup
(LaVision,  Germany)  consisting  of  an  upright  microscope  (Olympus  BX51WI)  and
imaging  software  ImSpector  Pro  (LaVision,  Germany)  was  used  for  ratiometric  Cl-
imaging. A 1.0 numerical aperture 20×  water immersion lens (Plan- APOCHROMAT,
Zeiss) was used for the experiment. Fluorescence was elicited using a Ti: Sapphire laser
(Mai Tai HP DeepSee, Spectra-physics, Mountain View, CA) tuned to 870 nm. CFP sig-
nals (filter: 480BP 36) and YFP signals (filter: 537 BP 42) were separated by a beam-
splitter (500 LP) and recorded simultaneously. Images were acquired from Clomeleon-
positive cells in whole DRG. The data were analyzed offline with ImageJ (http://rsbwe-
b.nih.gov/ij/) and Matlab (MathWorks, Natick, Massachusetts). The fluorescence in-
tensity of YFP (FYFP) and CFP (FCFP) and their associated background signal (BYFP and
BCFP) of DRG neurons were read out in ImageJ. The ratio of YFP and CFP intensity (
R=
FYFP−BYFP
FCFP−BCFP
), which is negatively correlated to the  Cl- concentration, and related
statistics were calculated in Matlab. 
3.7 Perforated patch clamp
Recordings were made from DRG neurons using fire-polished glass pipette with a resis-
tance of 3–7 MΩ. Extracellular solution contained 150 mM NaCl, 5 mM KCl, 2 mM
CaCl2, 1 mM MgCl2, 10 mM glucose and 10 mM HEPES (pH 7.4). Internal solution used
to fill glass pipette contained 140 mM KCl, 5 mM EGTA and 10 mM HEPES (pH 7.3).
Lucifer Yellow and gramicidin were freshly added into internal solution prio to record-
ing to reach to final concentration 0.1%  and 50 - 100 μg ml-1 respectivily. Membrane
current and voltage were amplified and acquired using EPC-10 amplifier (HEKA Elec-
tronik GmbH, Germany) sampled at 10 kHz. The formation of gramicidin perforation
were monitored by the Patchmaster programme (HEKA Electronik GmbH, Germany)
and the measurement was started until serious resistance dropped to < 40 MΩ. 1 mM
GABA was applied to recorded neuron at a series of holding potentials (-60, -40, -20, 0
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and 20 mV). Data was analysed with Fitmaster software (HEKA Electronik GmbH, Ger-
many). The reversal potential of GABA-induced current (ECl) was calculated using a se-
ries of current amplitudes recorded at various holding potentials. The conductance of
GABAA receptors was calculated according to ohm’s law.
3.8 Calcium imaging
3.8.1 Imaging of cultured DRG neurons 
Briefly,  fluorescence  microscopy  was  done  on  an  Observer  A1  inverted  microscope
(Zeiss, Germany) using a 0.8 numerical aperture 25× water immersion objective (Zeiss,
Germany), and a 175W Xenon lamp as a light source. Before imaging, DRG neurons
were incubated with 2 mM Fura-2 in extracellular solution containing 150 mM NaCl, 5
mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM glucose and 10 mM HEPES at 37 °C for 40
min and washed with extracellular solution at 37 °C for another 30 min. When IB4
marker (Sigma, Germany)  was used, cells were incubated with 2 µg ml- IB4 in extracel-
lular solution at 37 °C for 20 min directly after Fura-2 incubation.
Excitation light was passed either through a 340-BP 30 filter or a 387-BP 16 filter. Two
filters were switched by an ultra-high speed wavelength switcher Lambda DG-4 (Sutter,
Novato, CA). Emissions elicited from both excitation wavelengths were passed through
a 510-BP 90 filter and collected by a charge-coupled device camera (Zeiss). Different
solutions were applied by multi barrel perfusion system (WAS02, DITEL, Prague). Ax-
ioVision software (Zeiss) was used to record image data. After background (B340, B380)
subtraction in each channel (F340, F380), the ratio (R340/380) of fluorescence elicited by ex-
citation light at wavelength 340 nm and 380 nm, was calculated: R= (F340−B340)(F380−B380) . A high
KCl extracellular solution was used to stimulate neurons and generate calcium tran-
sient. It contains 115 mM NaCl, 40 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM glucose
and 10 mM HEPES. Drugs were perfused in either extracellular solution or high KCl ex-
tracellular solution. If the 4th highest R was larger than threshold (R0+5 stdR0 ) , the
cell was considered to show a calcium transient in response to a stimulus. Ro is the
mean value of baseline ratio. 
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Data were analyzed by using AxioVision and Matlab (MathWorks, Natick, Massachu-
setts).
3.8.2 Imaging of acute spinal cord slices
Spinal cord slice was transferred to recording chamber of the 2-photon setup and per-
fused with oxygenized Ringer's solution. 2-photon imaging setup is same as for chloride
imaging experiments, except the laser was tuned to 920 nm. GCaMP3 signal (filter: 562
BP 40) was recorded. Time series of images were acquired from the spinal cord dorsal
horn. Superficial layer of dorsal horn (not deeper than 100 mm from the spinal cord
dorsal outline) was imaged. Scanning frequency was 1 Hz. A high KCl Ringer's solution
was used to stimulate neurons. It contains 87 mM NaCl, 1.25 mM NaH2PO4, 26 mM
NaHCO3, 40 mM KCl, 2 mM MgCl2, 2 mM CaCl2, 10 mM glucose. To avoid the effect
of activation of glutamate receptor, 10 mM NMDA (N-methyl-D-aspartate) antagonist
(RS)-CPP (Tocris Bioscience, UK) and 10 mM AMPA (a-amino-3- hydroxy-5-methyl-4-
isoxazolepropionic acid) antagonist CNQX (abcamBiochem- icals, UK) were added into
high KCl Ringer's solution. Ringer's solution with 1mM GABA was used to investigate
neuron response to GABA. Short time perfusion with Ringer's solution with GABA fol-
lowed by high KCl Ringer's solution with CPP, CNQX and GABA was used to investigate
influence of  GABA on neuron excitation.  All  chemicals  were  either  perfused to  the
whole recording chamber or to the adjacent area of recording field (< 500 µm).
2-photon live imaging data was exported from LaVison customized version of ImSpec-
tor  software  (http://www.imspector.de),  and was  analyzed  offline  with ImageJ  and
Matlab (MathWorks, Natick, Massachusetts). Image stacks underwent sample moving
correction with ImageJ plugin, Image Stabilizer (K. Li, "The image stabilizer plugin for
ImageJ,"  http://www.cs.cmu.edu/~kangli/code/Image_Stabilizer.html,  February,
2008.), utilizing Lucas–Kanade method. Each recording was segmented into 5 x 5 µm
square shape regions of interest (ROIs).  Average of all  pixels'  intensity in each ROI
from a single frame was calculated and used as  fluorescence intensity (F).  All  data
points were also smoothed by using LOESS method, which is a local regression using
weighted linear least squares and a 2nd degree polynomial, with a span of 10% of data
points, and collected as FS.
Mean value of F and FS from 30 frames prior to simulation were used as baseline fluo-
rescence intensity (F0 and FSo).  180 frames following stimulation were used for re-
page 24 of 98
sponse analysis. When the maximum F (Fmax) from these 180 response frames exceeded
threshold (F0+5 stdF0 ) by  
(Fmax−Fmin)
2
 while  the  maximum FS (Fsmax)  exceeded
threshold (FS0+2 stdFS0 ) by 
(FSmax−FSmin)
2
, a ROI was considered to have a posi-
tive response.  stdF 0 And  std SF0 are the standard deviations of F0  and SF0 respec-
tively. Fmin and FSmin are the minimum F and FS from response frames. Fmax was con-
verted to ΔF using the formula ∆ F=Fmax−F0 . In a given ROI, GABA is considered
to  decrease  high  KCl  evoked  calcium  transient  and  have  inhibitory  effect  when
(∆ FKCl−∆ FK Cl+GABA )
∆ FKCl
>0.5 ,  or  there is  no response to high KCl Ringer's  solution
combine with GABA. When 
(∆ FKCl+GABA−∆ FKCl )
∆ FKCl
>0.5 , or the ROI responds to high
KCl Ringer's solution with GABA, but not high KCl Ringer's solution alone, GABA is
considered  to  facilitate  calcium  transient  evoked  by  high  KCl  and  be  excitatory.  If
|∆ FKCl−∆ FKCl+GABA|
∆ FKCl
⩽0.5 , GABA influence is categorized as no influence. 
 In GABA alone stimulation piece, only ROIs showed positive responses in KCl stimula-
tion piece from the same trial were used for analysis. 
3.9 Immunohistochemistry
Mice  were  deeply  anesthetized  with  isofluorane,  and  were  perfused  with  4%
paraformaldehyde (PFA) in PBS pH 7.4. DRGs and spinal cords were then dissected
from perfused mice and post-fixed with 1% and 4% PFA overnight respectively. 10% su-
crose in PBS 1h, 20% sucrose in PBS 1h, and 30% sucrose in PBS overnight incubation
were applied to all tissue.  For NKCC1 staining, DRGs and spinal cords were isolated
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from non-perfused animal and fixed with 2% PFA in PBS pH 7.4 overnight and then in-
cubated in 25% sucrose-hanks in PBS overnight.
O.C.T. compound (Tissue-tek, Sakura Finetek) were used to embed tissue and bind to
specimen block of cryotome (Leica) for slicing. 10 - 14 µm thick samples were mounted
on SuperFrostr®  Plus microscope slides (R. Langenbrinck Labor- u. Medizintechnik)
and stored at -20 °C. 
For CGRP and IB4 staining, the sections were permeablized and blocked with 0.1% Tri-
ton X-100 (Roth) and 5% donkey serum in PBS for 1 h, and incubated with primary an-
tibody anti-calcitonin gene-related peptide (CGRP) (goat, ab36001) diluted 1:1000, or
isolectin GS-IB4 (griffonia simplicifolia, Alexa Fluor® 568 conjugated, I21412) diluted
1:400 in PBS with 0.05% Triton X-100 and 5% donkey serum at 4 °C for 18 h. Sec-
ondary antibody donkey-anti-goat (cy3 conjugated) 1 h incubation at room temperature
was used to label CGRP antibody. To label NKCC1, the sections were permeablized 3
min  with  0.1%  Triton  X-100  (Sigma-Aldrich)  in  PBS,  blocked  30  min  in  1%  BSA
(Sigma-Aldrich) in PBS, and incubated with primary antibody anti-NKCC1 (goat, Santa
Cruz Biotechnology) diluted 1:500 at 4 °C for 18 h followed by 1h secondary antibody,
donkey-anti-goat (cy3 conjugated) incubation at room temperature.
Coverslips were mounted with vectashield mounting medium (Vector Laboratories, Inc.
Burlingame). Samples were imaged with epifluorescence microscope (Zeiss) equipped
with fluorescence lamp and monochrome camera. The acquired images were analyzed
using ImageJ (NIH, Bethesda, MD; USA).
3.10Real-time PCR
Total RNA was extracted from DRGs using peqGOLD TriFast (peqlab) following the
manufacturer’s  protocol.  RNA  was  determined  with  a  peqlab  NanoDrop  ND-1000.
Complementary DNA was synthesized from 5 mg of total RNA using the SuperScript
TM  II  Reverse  Transcriptase  kit  (Invitrogen,  Carlsbad,  CA,  USA)  with  oligo(dT)
primers, according to the manufacturer’s protocol. 
The volume of each reaction was 20 µl composed of 10 µl ABsolute QPCR SYBR Green
ROX Mix  (Thermo Scientific),  1  µl  1:5  diluted  cDNA and 1  µl  forward  and reverse
primers.  3  replications were prepared for  every  test.  The real-time PCRs were per-
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formed on an ABI 7500 Real Time PCR System (ABS/ Life Technologies). Primers used
were listed in Table 1.  
Relative amounts of mRNA were determined using comparative CT method67. In brief,
CT of  each  reaction  was  readout,  ΔCT was  calculated  using  ∆ CT=CT−CT (GAPDH ) .
CT(GAPDH) is the CT value of housekeeping gene GAPDH. Then ΔΔCT was calculated with
∆ ∆CT=∆ CT−∆ CT (control) . ∆CT(control) is the ΔCT of the tested gene from control sam-
ple. Finally, the fold change was calculated as 2−ΔΔCT . 
Gene Forward (5’ - 3’) Reverse (5’ - 3’)
Gabra1 CCAAGTCTCCTTCTGGCTCAA
CA
GGGAGGGAATTTCTGGCACT
GAT
Gabra2 TTACAGTCCAAGCCGAATGTC
CC
ACTTCTGAGGTTGTGTAAGCG
TAGC
Gabra3 CAAGAACCTGGGGACTTTGTG
AA
AGCCGATCCAAGATTCTAGTG
AA
Gabra5 CGCGTAGGCGTCAAGATCAA
GT
TCATAGCCATCCAAGAGTCCG
TC
Gabrb3 GCC AGC ATC GAC ATG GTT 
TC
GCG GAT CAT GCG GTT TTT 
CA
NKCC1 TCC TCA GTC AGC CAT ACC 
CAA A
ATC CCG AAC AAC ACA CGA 
ACC
BDNF AGT CTC CAG GAC AGC AAA 
GC
TCG TCA GAC CTC TCG AAC 
CT
Trkb truncated ATC TGC AAC GAC GAT GAC 
TCT G
GTA GCA CTC GGC AAG GAA 
AAC T
Trkb full-length CCC AAA TTA CCC TGT AGT 
CCT CT
ACC CAT CCA GTG CGA TCT 
TAT
GAD65 CGC ATT GCC AAA CAA CTC 
TAA A
AGT CTG CTG CTA ATC CAA 
CCA T
GAD67 GCC ACA AAC TCA GCG GCA 
TA
CCC GGT GTC ATA GGA GAC 
GT
GAT1 CTC CAA CTA CAG CCT GGT 
CAA TAC
GCA GAA ATA CAC GAG CAC 
CCA
GAPDH ACC CTG TTG CTG TAG CCG 
TAT CA
TCA ACA GCA ACT CCC ACT 
CTC CA
Table 1: Sequence of primers used for real-time PCR experiments.
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4 Results
4.1 GABAergic presynaptic modulation after 
peripheral nerve injury 
4.1.1 Increased [Cl-] in DRGs after nerve injury 
Chronic  constriction  injury  (CCI)  of  sciatic  nerve was  reported  to  generate  various
pathological symptoms, such as mechanical allodynia, mechanical and thermal hyper-
algesia, and therefore is widely used as an animal model to study neuropathic pain44.
The effect of CCI in mouse had been assessed by my colleague with von Frey and plan-
tar tests and confirmed that both mechanical and thermal pain behaviors were induced
in this injury model61. The sensitivity of injured mice reached to peak 2 days after CCI,
and lasted at least 28 days. My interest is the early stage of chronic pain development,
therefore, 2 days post injury animal were used for further study.
The principle inhibitory effect of GABA is achieved by activating GABAA receptor which
generate chloride current and hyperpolarize cell. Therefore, the intracellular chloride
concentration is crucial. Coull et al. reported potassium-chloride cotransporters KCC2
on lamina I  projection neurons  were downregulated after  peripheral  nerve injury50.
This event, in turn, elevated intracellular [Cl-]. As a result, GABA induced postsynaptic
inhibition on projection neurons was lost or even switched to excitation due to chloride
gradient shift. I wondered whether peripheral nerve injury could also change the intra-
cellular [Cl-] in presynaptic DRG neurons, and interfere presynaptic inhibition. There-
fore, 2-photon chloride imaging were performed on acutely dissected DRGs from trans-
genic clomeleon mice, which express chloride indicators in neurons, to investigate if
CCI influence the [Cl-] of DRG neurons (Figure 6). These indicators contain both CFP
and YFP fluorophores. The ratio of YFP to CFP fluorescence (YFP/CFP) negatively cor-
relates with [Cl-].  I observed significantly decrease of YFP/CFP, representing the in-
crease of [Cl-], in both small (Control: 0.18 ± 0.003; CCI 0.13 ± 0.004) and large diam-
eter DRG neurons (Control: 0.20 ± 0.003; CCI: 0.13 ± 0.002) from nerve injured mice
(Figure 6). 
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My colleague, Jeremy Tsung-Chieh Chen, performed perforated patch clamp to investi-
gate the function of Cl- permeable GABAA receptors of DRG neurons from intact and
nerve injured mice (Figure 7). The results indicated that the reversal potential of Cl -
(ECl) are – 35.2 ± 2.5 mV and – 37.5 ± 2.4 mV in small and large neurons repectively
from control mice. And nerve injury depolarizingly shifted ECl in both small (22.7 ± 2.4
mV) and large neurons (– 28.3 ± 3.4 mV respectively). The depolarizing shift of ECl sug-
gests an increase of intracellular [Cl-] which is consistent with my chloride imaging re-
sult.  Noticeably,  the conductance of  GABAA receptors  (GGABA)  was downregulated in
both small and large neurons by nerve injury (Figure 7d).  
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Figure  6:  CCI  upregulate  intracellular  [Cl-]  of  DRG neurons.  (a)  The 2-photon images of
Clomeleon signal (FYFP/FCFP) in acutely dissected DRGs from intact (left) and 2-day post CCI
animal. (b) The increase of intracellular [Cl-] in both small and large DRG neurons after CCI
indicated by the decrease of  FYFP/FCFP (small control: n = 73; small CCI: n = 63; large control:
n = 58; large CCI n= 114; small control vs small CCI, unpaired student t-test, P < 0.001; large
control vs large CCI, unpaired student t-test, P < 0.001). Error bars indicate standard error of
the mean (SEM). Scale bars (a) 50 μm. ***P < 0.001.
In conclusion, nerve injury caused an increase of [Cl-] possibly potentiating the depo-
larization induced by activation of GABAA receptors. However, the associated decrease
of GGABA may limit such depolarization. 
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Figure  7:  Nerve injury (CCI)  induced a transient  depolarizing shift  of ECl and reduction of
conductance of GABA induced current in primary sensory neurons. (a) Representative traces
of GABA-activated currents recorded in DRG neurons during gramicidin perforated patch at
various holding potential mV. (b) Current–voltage relationship for GABA-activated response
from large (left)  and small  (right)  neurons.  (c)  Bar  graph showing the time course of  the
changes in ECl.  (d)  Bar graph showing the time course of the changes in conductance of
GABAA receptors. The number of neurons recorded is indicated on top of each bar in (c) and
(d). *P < 0.05; **P < 0.01; unpaired t-test. Error bars indicate SEM.
4.1.2 Proportion of DRG neurons activated by GABA is not 
changed by nerve injury 
Due to the nature that DRG neuron [Cl-] is high enough to cause the ECl more depolar-
ized than membrane potential, the activation of GABAA receptors would lead to an out-
flow of chloride ions and depolarize the cell39,40. This depolarization, as previous studies
advocated, was suggested to be the principal component of presynaptic inhibition in-
duced by GABA28. However, when this depolarization reaches firing threshold, the in-
hibitory  effect  could  be impaired.  The  CCI  generated  rise  of  [Cl-]  in  DRG neurons
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Figure 8: CCI did not change the proportion of DRG neurons displaying GABA evoked calcium
transient. (a) The bright field (left) and Fura-2 signal (F340/F380) images taken before (middle)
and immediately after (right) GABA application. (b) Representative traces showing intracellular
[Ca2+] along time in labeled cells in  a.  (c) Proportions of neurons displaying GABA evoked
calcium transient (small control:  n = 236; small CCI: n = 149; small BDNF: n = 110; large
control: n = 45; large CCI: n = 19; large BDNF n = 30; Fisher’s exact test, all P > 0.05). Scale
bar (a)  30 μm.
caused a larger electrical potential across membrane, which might increase the GABAA
receptor  mediated  chloride  current  outflow.  Whether  the slightly  elevated  [Cl-]  can
change the effect of GABA, for example,  to excitation is  unclear.  To figure this out,
DRGs from intact and injured animal were cultivated, and used for Fura-2-AM loaded
cell calcium imaging, which indirectly showed neuron activity by monitoring intracellu-
lar calcium influx (Figure 8a). Locally applied 1 mM GABA, which is in the same con-
centration range as in synaptic cleft, was found to trigger calcium transient in 44% of
small neurons and 24% of large neurons from intact animal  (Figure 8c). And these
proportions were not significantly changed in neurons from injured mice (38% in small
neurons, 16% in large neurons)  (Figure 8c).  This result showed that the GABA in-
duced depolarization could not trigger calcium transient in a bigger proportion of DRG
neurons after nerve injury. This may be due to the downregulated GGABA, which limits
the inward current to depolarize neurons.  
4.1.3 GABA loses inhibitory effect on presynapses in nerve 
injured mice
The intracellular [Cl-] increase was observed in DRG neuron somas from nerve injured
mice, but whether [Cl-] in central terminals, which locate in spinal cord dorsal horn,
rise together with neuron somas is still unclear. Besides, GABA was not found to ac-
quire excitatory effect on DRG neurons from injured mice, but its effect on presynapses
is still unclear if [Cl-] also rises there. Therefore, 2-photon calcium imaging was utilized
to investigate the central terminals of nociceptors.
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To cope with the difficulty of recognizing presynapses, I bred SNS-Cre mice, which ex-
pressed Cre recombinase in nociceptors, to Ai38 mice, in which a loxP-flanked STOP
cassette  prevented  transcription  of  the  downstream  fluorescent  calcium  indicator
GCaMP3 fusion  gene.  The offspring  (SNS-Ai38)  carried both Cre  recombinase  and
GCaMP3 fusion gene had GCaMP3 specifically expressed in nociceptors and thus all
calcium signal observed in spinal cord was from central terminals of neurons (Figure
9a).
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Figure 9: 2-photon images of acutely
dissected  spinal  cord  slices  from
SNS-Ai38  mice  (control,  CCI  and
BDNF).  (a)  A  diagram  showing
expression patter of GCaMP3 signal
in advillin-Ai38 mice. (b) Bright field
image of spinal cord slice used for 2-
photon  calcium imaging.  (c -  n)  2-
photon  microscope  imaged
GCaMP3 signal indicating [Ca2+] in
Control (c - f), CCI (g - j) and BDNF
(k - n) spinal cord superficial layer in
response  to  various  stimuli.  Scale
bars, (b) 200 μm; (c - n) 10 μm (only
shown in n)
Spinal cord innervated by L4 or L5 nerve were sliced and superficial layers of dorsal
horn, where most nociceptors innervate, was imaged with 2-photon microscopy (Fig-
ure 9b). Considering synaptic GABAA receptors are less sensitive to GABA compare to
extrasynaptic GABAA receptors68, and the perfusion to whole recording chamber might
unable to deliver the expected concentration (1 mM) of GABA and activated majority of
synaptic  GABAA receptors,  recordings  with local  perfusion  (less  than 500 μm from
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Figure  10:  The  color  maps  and  representative  traces  of  2-photon  calcium imaging  of
acutely dissected spinal cord slices from SNS-Ai38 mice (control, CCI and BDNF). (a, c, e)
Each color map represents presynaptic calcium intensity in 30 ROIs. (b, d, f)  Selected
representative traces showing calcium intensity. The figures for control (a, b), CCI (c, d)
and BDNF (e, f) groups are correlated with the example 2-photon images show in Figure
9. 
recording area) in addition to whole chamber perfusion were applied to ensure the acti-
vation of GABAA receptors. Clear calcium transient (ΔF/F0) was observed when high
KCl Ringer’s solution, with or without GABA, was applied (Figure 9d, f, h, j; 10a - d).
Noticeably, when GABA was co-applied with high KCl Ringer’s solution, majority of
high KCl responding regions of interest (ROIs) either showed similar amplitude of cal-
cium transient or attenuated calcium influx or even no influx (Whole chamber perfu-
sion: No-change: 58 %; More Ca2+ transient: 7 %; Less Ca2+ transient: 36 %. Local per-
fusion: No-change: 49 %; More Ca2+ transient: 9 %; Less Ca2+ transient: 41 %. Figure
11a). And nerve injury dramatically decreased the proportion of ROIs where GABA ex-
hibited such inhibitory effect on KCl evoked calcium transient, and boosted the propor-
tion  showing elevated calcium transient  when GABA was  co-applied  with high  KCl
(Whole chamber perfusion: CCI: No-change: 46 %; More Ca2+ transient: 45 %; Less
Ca2+ transient: 9 %. Local perfusion: CCI: No-change: 67 %; More Ca2+ transient: 30 %;
Less Ca2+ transient: 3 %. Figure 11a). 1 mM GABA perfused to the recording chamber
could trigger calcium transient in a small percentage of ROIs in spinal cord from intact
SNS-Ai38 mice (Whole chamber perfusion: 2.7 ± 1.3 %. Local perfusion: 12.5 ± 2.3 %.
Figure 11b), and nerve injury did not show significant influence on this percentage
(Whole chamber perfusion: 1.3 ± 0.7 %. Local perfusion: 19.8 ± 4.7 %.  Figure 11b). In
conclusion, these results showed the considerable inhibitory effect of GABA on nocicep-
tor  central  terminals,  and nerve injury  significantly  disturbed this  negative  control.
However, presynaptic GABAergic control, unlike postsynaptic inhibition, was not re-
versed to be excitatory, but was only disinhibited, since GABA did not generate more
calcium influx after nerve injury. 
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4.1.4 Lost of presynaptic inhibition after nerve injury 
contributes to mechanical hypersensitivity and fully 
responsible for thermal hyperalgesia (experiments carried by 
Jeremy Tsung-chieh Chen)
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Figure  11: statistics results of 2-photon calcium imaging on spinal cord from SNS-Ai38 mice
(control, CCI and BDNF). (a) The proportions of ROIs where no-change, more Ca2+ transient,
and less Ca2+ transient were observed when 1 mM GABA was applied with high KCl compare to
sole high KCl perfusion. The number of ROIs recorded is indicated on top of each bar. (whole
chamber perfusion: Control mice n = 5; CCI mice n = 4; BDNF mice n=3. chi-squared  test,
Control vs CCI, P < 0.001; Control vs BDNF, P < 0.001. local perfusion: Control mice n = 4; CCI
mice n = 3; BDNF mice n=3. chi-squared test, Control vs CCI, P < 0.001; Control vs BDNF, P <
0.001). (b) The proportion of ROIs displaying GABA evoked calcium transient was not changed
by CCI or BDNF incubation (whole chamber perfusion: Control slice, n = 6; CCI slice, n = 5;
BDNF slice, n = 5. student t-test, Control vs CCI, P > 0.05; Control vs BDNF, P > 0.05. Local
perfusion: Control slice, n = 8; CCI slice, n = 7; BDNF slice, n = 4. student t-test, Control vs CCI,
student t-test, P > 0.05; Control vs BDNF, student t-test, P > 0.05.). Error bars indicate SEM.
***P < 0.001.
The group of De Koninck50,51 provided evidence that mechanical allodynia and thermal
hyperalgesia in peripheral nerve injured mice were at least partially caused by the in-
creased postsynaptic chloride gradient which alters inhibitory GABAergic input from
interneurons. Witschi et al.69 recently selectively knockout GABAA receptor α2 subunit
on DRG nociceptors (SNS-α2-/-) by utilizing Cre-loxP method. Although, the antinoci-
ceptive effect of Diazepam (DZP) was found to be reduced in these SNS-α2-/- mice, the
thresholds to thermal and mechanical stimulation were normal, which might because
of the upregulation of bensodiazepine insensitive GABAA receptors. My colleague, by
using  SNS-cre  and  Gabrb3-loxP  mice,  generated  conditional  knockout  mouse  line
(SNS-β3-/-) in which another GABAA receptor subunit, β3, was specifically knockout in
nociceptors. Compare to control litter mates, β3fl/fl mice, SNS-β3-/- mice were signifi-
cantly more sensitive to both thermal and mechanical stimulation, yet nerve injury was
still capable of further sensitizing mechanical sensitivity (Figure 12a). However, heat
hypersensitivity could not  be further  developed (Figure 12b).  My calcium imaging
data and these behavior results together suggest that nerve injury disrupts presynaptic
inhibition, and this lost of inhibition contributes to mechanical hypersensitivity and is
fully responsible for thermal hyperalgesia.
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Figure 12: SNS-β3-/- mice were more sensitive to both mechanical and thermal stimuli. (a) Von
Frey test showed mechanical hypersensitivity was significantly reduced in SNS-β3−/−  mice, and
mechanical allodynia was further developed after CCI. n = 6 mice per group. (repeated two-way
ANOVA, β3fl/fl ipsilateral versus SNS-β3−/− ipsilateral, factor time, P < 0.001; factor genotype, P <
0.001. Bonferroni post hoc test, β3fl/fl ipsilateral versus SNS-β3−/− ipsilateral 0d, P < 0.05). (b)
SNS-β3−/− mice failed to develop thermal hypersensitivity after CCI. n = 6 mice per group. (Two-
way analysis of variance (ANOVA): β3fl/fl contralateral versus ipsilateral, P < 0.001; SNS-β3−/−
contralateral versus ipsilateral, P < 0.05; β3fl/fl ipsilateral versus SNS-β3−/− ipsilateral after injury,
P > 0.05). Error bars indicate SEM.
4.1.5 BDNF causes the lost of presynaptic inhibition after nerve
injury
Coull et al. revealed that the elevated [Cl-] in lamina I neurons after nerve injury were
caused by microglia released BDNF which down-regulates KCC2 by binding to TrkB re-
ceptors51. BDNF-TrkB signaling had been suggested to modulating intracellular [Cl-] by
regulating NKCC1, which is mainly expressed by DRG neurons, as well as KCC270,71. In
addition, TrkB receptors had been reported to also expressed at axonal terminals of pri-
mary afferent fibers in nociceptors, and depolarizing shift of chloride reversal potential
was observed in BDNF treated DRG neurons as well61,72. Therefore, it is likely that the
microglia-derived BDNF after nerve injury also has an impact on presynaptic [Cl-]. To
examine this  assumption,  calcium imaging on overnight  BDNF (50 ng ml -1)  treated
DRG cell culture was applied. GABA induced calcium transient didn’t appear in bigger
proportion of neurons compare to control, which is similar to result acquired from in-
jured mice (BDNF: small, 43 %; large, 43 %. Figure 8c).
2-Photon calcium imaging was also applied to examine the effect of BDNF on presy-
napses (Figure 9k – n; 10e – f; 11). 2h BDNF incubated spinal cord slice from SNS-
Ai38 mice exhibited a prominent loss of GABAergic inhibition on high KCl induced cal-
cium influx in presynapses located in superficial layer (Whole chamber perfusion: No-
change: 97 %; More Ca2+ transient: 2 %; Less Ca2+ transient: 2 %. Local perfusion: No-
change: 72 %; More Ca2+ transient: 7 %; Less Ca2+ transient: 21 %.), which is identical to
the change in CCI spinal cord (Figure 11a). Similarly, the proportion of ROIs display-
ing GABA-evoked calcium transient (Whole chamber perfusion: 5.2 ± 2.8 %. Local per-
fusion: 25.3 ± 7.2 %) was also unaffected (Figure 11b).  
In addition, our group previously provided behavior evidence showing BDNF and CCI
had similar effect on presynaptic terminals61. Taken together, these similarities between
CCI and BDNF groups implied the nerve injury induced lost of presynaptic inhibition is
regulated by BDNF.
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4.2 GABAergic presynaptic modulation after 
peripheral inflammation 
4.2.1 Increased [Cl-] associated with unchanged GGABA in 
nociceptors after inflammation (experiments carried by Jeremy 
Tsung-chieh Chen)
Willis had reviewed dorsal root reflex (DRR), which is only observed after peripheral
inflammation but not nerve injury, and discussed the possible mechanism causing it52.
Pharmacological studies strongly suggested that the enhanced PAD mediated by presy-
naptic GABAA receptors after inflammation was essential for DRR. Therefore, we rea-
soned that peripheral inflammation, similar to nerve injury, also likely to elevate the in-
tracellular [Cl-], which may cause a depolarization strong enough to trigger an action
potential. Indeed,  Patch clamp study from our lab revealed that CFA injection did in-
duce a depolarizing shift of ECl in small sized DRG neurons (Figure 13). Moreover, the
whole cell GGABA did not decrease like neurons from nerve injured animal and rather
show a trend towards increasing (Figure 13). Together, these electrophysiology results
implied that the activation of GABAA receptors probably generated a stronger depolar-
ization after peripheral inflammation than after nerve injury, which possibly underlied
why DRR was not observed after nerve injury.        
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My colleague found both similarities and distinctions between nerve injured and CFA
injected SNS-β3-/- mice with behavior test. CFA injection induced peripheral inflamma-
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Figure  13:  The  influence  of  CFA induced  inflammation  on  ECl and  GGABA of  cultured  DRG
neurons. (a - b) Representative traces displaying GABA generated currents in large (a) and
small (b) neurons at various holding potential. (c - d) The current – voltage curve of GABA
induced cell responses in large (c) and small (d) neurons. (e) ECl was depolarizingly shifted in
small neurons 2 days after CFA injection. This shift was recovered after 4 weeks. (student t-test,
Large: Control vs CFA 2 days, P > 0.05; Control vs CFA 4 weeks, P > 0.05; CFA 2 days vs CFA
4 days, P > 0.05. Small: Control vs CFA 2 days, P < 0.05; Control vs CFA 4 weeks, P > 0.05;
CFA 2 days vs CFA 4 days,  P < 0.05).  (f)  The conductance of  GABAA receptors was not
affected  by  CFA injection  in  neither  larger  nor  small  DRG neurons.  (student  t-test,  Large:
Control vs CFA 2 days, P > 0.05; Control vs CFA 4 weeks, P > 0.05; CFA 2 days vs CFA 4
days, P > 0.05. Small: Control vs CFA 2 days, P > 0.05; Control vs CFA 4 weeks, P > 0.05; CFA
2 days vs CFA 4 days, P > 0.05). The number of recorded neurons in indicated on top of each
bar in (e) and (f). Error bars indicate SEM. *P < 0.05.   
tion further developed the mechanical and thermal hyperalgesia in SNS-β3-/-  mice as
CCI (Figure 14a, b), yet mechanical allodynia was not fully developed after inflamma-
tion (Figure 14c). This indicates that presynaptic GABAA receptors are crucial for me-
chanical allodynia development after inflammation which was not observed in nerve in-
jured animal. 
4.2.2 Excitatory effect of GABA on presynapses in inflamed 
mice
Therefore, I studied the function of presynaptic GABAA receptors with spinal cord (SC)
slices from CFA injected animal to investigated whether the increased [Cl-] abolishes
the inhibitory effect of GABA as it does in nerve injured animal, and whether the differ-
ence in GGABA between CCI and CFA groups leads to functional difference. 
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Figure  14:  CFA induced  peripheral  inflammation  further  sensitized  SNS-β3-/- mice.  (a)  The
mechanical  allodynia  was developed in  SNS-β3-/- mice  after  CFA injection,  but  it  was  less
sensitive than that in β3fl/fl mice. (β3fl/fl, n = 6; SNS-β3-/-, n = 8. Repeated two-way ANOVA (0 -
28d): factor time P < 0.0001, factor genotype P < 0.0001, Bonferroni post hoc, β3fl/fl vs SNS-β3-/-
on 0d,  P  <  0.0001.  Repeated  two-way  ANOVA (1  –  28d):  factor  time  P  <  0.0001,  factor
genotype P < 0.01).  (b) The development of thermal hyperalgesia was similar in SNS-β3-/- and
its control litter mates (β3fl/fl, n = 6; SNS-β3-/-, n = 8. Repeated two-way ANOVA (0 - 28d): factor
CFA injection, β3fl/fl contralateral vs ipsilateral, P < 0.0001; SNS-β3-/- contralateral vs ipsilateral,
P < 0.0001. Repeated two-way ANOVA (1 – 28d)  β3fl/fl vs SNS-β3-/- ipsilateral, P > 0.05). (c)
Error bars indicate SEM. 
2-day after CFA injection, GABA was found, like in nerve injured mice, failing to sup-
press high KCl Ringer's solution generated calcium transient in spinal cord from SNS-
Ai38 mice (Whole chamber perfusion: No-change: 66 %; More Ca2+ transient: 21 %;
Less Ca2+ transient: 13%. Local perfusion: No-change: 68 %; More Ca2+ transient: 31 %;
Less Ca2+ transient: 1 %. Figure 15; 16; 17a). In addition, GABA itself alone could gen-
erate calcium influx in more presynapses in spinal cord from CFA injected SNS-Ai38
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Figure  15:  2-photon  images  of
acutely  dissected  spinal  cord
slices from SNS-Ai38 mice.(a) A
diagram  showing  expression
patter  of  GCaMP3  signal  in
SNS-Ai38  mice.  (b)  2-photon
microscope  imaged  GCaMP3
signal  indicating  [Ca2+]  in
Control  (b - e),  CCI (f  -  i)  and
CFA  (j  -  m)  spinal  cord
superficial  layer  in  response  to
various stimuli. Scale bars, (b –
m) 10 μm (only shown in m).
mice (Whole chamber perfusion: Control: 2.7 ± 1.3 %; CFA: 6.6 ± 0.9 %. Local perfu-
sion: Control: 13 ± 2.3 %; CFA: 57 ± 12 %. Figure 15i; 16e,f; 17b).
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Figure 16:  The color maps and representative traces of 2-photon calcium imaging of acutely
dissected spinal cord slices from SNS-Ai38 mice (control, CCI, CFA). (a, c, e) Each color
map represents presynaptic calcium intensity in 30 ROIs. (b, d, f) Selected representative
traces showing calcium intensity. The figures for control (a, b), CCI (c, d) and CFA (e, f)
groups are correlated with the example 2-photon images show in Figure 15.  
2-photon calcium imaging with GABA receptor antagonists was performed to investi-
gated the contribution of GABAA and GABAB receptors to this increased calcium influx
after inflammation. As expected, GABA only induced calcium transient in few ROIs in
spinal  cord  from  intact  SNS-Ai38  mice,  and  neither  GABAB receptor  antagonist,
CGP55845, nor GABAA receptor antagonists, bicuculline and picrotoxin, changed this
(GABA:  4.6  ±  0.8  %;  GABA+CGP55845:  4.7  ±  2.4  %;
GABA+CGP55845+Bicuculline+Picrotoxin: 5.9 ± 2.9 %.  Figure 18c – e; 19a, c). In
spinal slices from CFA injected SNS-Ai38 mice, CGP55845 did not show any influence
on GABA-evoked calcium transient (GABA: 31 ± 5.8 %; GABA+CGP55845: 31 ± 5.0 %.
Figure 18h – i; 19b, c). However, bicuculline and picrotoxin successfully suppressed
the calcium transient in majority of ROIs, indicating the essential role of GABAA recep-
tors in the inflammation induced increase of GABA activity (GABA+CGP55845+Bicu-
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Figure 17: Statistics data of 2-photon calcium imaging on spinal cord from nerve injured SNS-
Ai38 mice. (a) The proportions of ROIs where no-change, more Ca2+ transient, and less Ca2+
transient were observed when 1 mM GABA was applied with high KCl compare to sole high KCl
perfusion.  The number  of  ROIs recorded  is  indicated  on top of  each bar.  (whole  chamber
perfusion: Control mice n = 5; CCI mice n = 4; BDNF mice n = 3; CFA mice n = 6. chi-squared
test, Control vs CCI,P < 0.001; Control vs BDNF, P < 0.001; Control vs CFA, P < 0.001. Local
perfusion: Control mice n = 4; CCI mice n = 3; BDNF mice n=3; CFA mice n = 3. chi-squared
test, Control vs CCI, P < 0.001; Control vs BDNF, P < 0.001; Control vs CFA, P < 0.001). (b)
The proportion of ROIs displaying GABA evoked calcium transient. (whole chamber perfusion:
Control, n = 6; CCI, n = 5; BDNF, n = 5; CFA, n = 12. student t-test, Control vs CCI, P > 0.05;
Control vs BDNF, P > 0.05; Control vs CFA, P < 0.05. Local perfusion: Control, n = 8; CCI, n =
7; BDNF, n = 4; CFA, n = 8. student t-test, Control vs CCI, P > 0.05; Control vs BDNF, P > 0.05;
Control vs CFA, P < 0.01.). Error bars indicate SEM. *P < 0.05, ***P < 0.001.
culline+Picrotoxin: 6.8 ± 3.0 %.  Figure 18j; 19b, c).In conclusion, these results im-
plies GABA does not only lose inhibitory effect, but also acquires excitatory effect in in-
flammatory pain model, which supports the previous report that the increased DRRs
were mediated by the activation of GABAA receptors after peripheral inflammation73.
And the incomplete developed allodynia of CFA injected SNS-β3-/- mice observed by my
colleague may be due to the lack of GABA excitatory effect on presynapses after inflam-
mation.
page 45 of 98
Figure  18:   2-photon images of  acutely
dissected  spinal  cord  slices  from SNS-
Ai38  mice  showing  the  effect  of
antagonists  of  GABAA and  GABAB
receptors. (a – e)  The 2-photon images
taken from Control group. (f – j) The 2-
photon  images  taken  from  CFA  group.
Scale bars, (a – j) 10 μm (only shown in
j)
4.2.3 mRNA level of proteins related to the function of 
presynaptic GABAA receptors 
The effect of GABAA receptors mainly depends on 3 factors, the Cl- gradient, GABA con-
centration and the density of GABAA receptors. If the Cl- gradient is larger, the electro-
chemical driven force would be bigger at the same resting potential. Previous studies
reported that the sodium potassium chloride co-transporter (NKCC1) is crucial for the
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Figure 19: The GABA induced calcium transient increase in SNS-Ai38 mouse spinal superficial
layer after peripheral inflammation is mediated by GABAA receptors. (a) Color map displaying
intact SNS-Ai38 mouse spinal superficial layer presynaptic [Ca2+] change in 30 ROIs chosen
from the area shown in Figure 18a – e. (b) Color map displaying CFA injected SNS-Ai38 mouse
spinal superficial layer presynaptic [Ca2+] change in 30 ROIs chosen from the area shown in
Figure 18f – j. (c) The proportion of ROIs displaying GABA evoked calcium transient grew after
CFA injection. This increase was prohibited by co-application of  GABAA receptor antagonists,
bicuculline and picrotoxin, with 1 mM GABA (SNS-Ai38 Control, n = 5; SNS-Ai38 CFA, n = 8.
SNS-Ai38  Control:  GABA  vs  GABA+CGP55845,  student  t-test,  P  >  0.05;  GABA  vs
GABA+CGP55845+Bicuculline+Picrotoxin, student t-test, P > 0.05; SNS-Ai38 CFA: GABA vs
GABA+CGP55845,  student  t-test,  P  >  0.05;  GABA  vs
GABA+CGP55845+Bicuculline+Picrotoxin, student t-test, P < 0.01). Error bars indicate SEM.
**P < 0.01.    
Cl- homeostasis in DRG neurons38,74,75. And our group had provided evidence that the
activity of NKCC1 is important for transient hypersensitivity of  mice after nerve in-
jury61. Our previous study also showed BDNF-TrkB signaling on DRG neurons generate
a raise in intracellular [Cl-] in nerve injured animal61. I therefore examined mRNA lev-
els of all these proteins (NKCC1, BDNF, full length and truncated TrkB), which might
be in the signaling pathway upregulating intracellular [Cl-], in DRGs (Figure 20) and
spinal cord dorsal horn (Figure 21) from intact and CFA injected mice with qRT-PCR.
BDNF was found increased in ipsilateral side of both DRGs (Control: 1.00 ± 0.01; CFA:
11.68 ± 2.59) and spinal dorsal horn (Control: 1.00 ± 0.04; CFA: 1.69 ± 0.13) after CFA
injection, which is consistent with previous studies, while mRNA of full-length (DRG:
Control: 1.00 ± 0.01; CFA: 1.00 ± 0.12. SC: Control: 1.01 ± 0.02; CFA: 0.97 ± 0.03),
truncated TrkB receptors (DRG: Control: 1.00 ± 0.01; CFA: 1.23 ± 0.19. SC: Control:
1.03 ± 0.02; CFA: 1.08 ± 0.05) and NKCC1 did not show significant change (DRG: Con-
trol: 1.00 ± 0.01; CFA: 1.04 ± 0.13. SC: Control: 1.05 ± 0.03; CFA: 1.11 ± 0.06). 
The concentration of GABA can be regulated by 2 glutamic acid decarboxylase (GAD),
GAD65 and GAD67, which are enzymes catalyzing the decarboxylation of glutamate to
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Figure 20: mRNA levels of proteins potentially influencing presynaptic GABAergic control
in DRG (Control, n = 9; CFA, n = 9. Student t-test, Control vs CFA: BDNF, P < 0.001; trkB
full-length,  P > 0.05;  trkB truncated,  P > 0.05;  NKCC1,  P > 0.05;  GAD67,  P > 0.05;
Gabra1, P < 0.01; Gabra2, P < 0.01; Gabra3, P > 0.05; Gabra5, P < 0.01; Gabrb3, P >
0.05). Error bars indicates SEM. **P < 0.01, ***P < 0.001 
GABA, and GABA transporter 1 (GAT1) functioning as a GABA remover. None of them
had a change on mRNA level in spinal cord after CFA injection (GAD65: Control: 1.03 ±
0.04; CFA: 1.01 ± 0.06. GAD67: Control: 1.00 ± 0.02; CFA: 0.96 ± 0.04. GAT1: Con-
trol: 1.01 ± 0.o3; CFA: 0.97 ± 0.05), likewise GAD67 mRNA remained at the same level
in DRGs (Control: 1.01 ± 0.04; CFA: 0.88 ± 0.14). CT  value of GAD65 was found very
high (> 30) in DRGs, which represented the mRNA level was too low for reliable test,
and thus not used for analysis. mRNA level of GABA remover, GAT1, in DRGs was not
examined, since all primary afferents are excitatory13. 
Each GABAA receptors is composed of 5 subunits, and interface(s) between  α and β
subunit is/are binding site(s) for GABA76. α1-3, α5, and β3 subunits were reportedly ex-
pressed in DRG neurons77. Any change of these subunits may lead to the unexpected ef-
ficacy of GABA, therefore mRNA levels of these subunits were examined (Figure 20;
21). α1 and α2 subunits were found decreased in both DRG (gabra1: Control: 1.00 ±
0.004; CFA: 0.78 ± 0.06. gabra2: Control: 1.00 ± 0.01; CFA: 0.85 ± 0.06) and spinal
cord (gabra1: Control: 1.04 ± 0.03; CFA: 0.93 ± 0.02. gabra2: Control: 1.05 ± 0.01;
CFA: 0.90 ± 0.02)  after  inflammation,  while  α5 subunit  was elevated only in DRG
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Figure  21:  mRNA levels  of  proteins potentially influencing presynaptic GABAergic control  in
spinal dorsal horn ipsilateral side (Control, n = 18; CFA, n = 15. Student t-test, Control vs CFA:
BDNF, P < 0.001; trkB full-length, P > 0.05; trkB truncated, P > 0.05; NKCC1, P > 0.05; GAD65,
P > 0.05; GAD67, P > 0.05; GAT1, P > 0.05; Gabra1, P < 0.01; Gabra2, P < 0.01; Gabra3, P >
0.05; Gabra5, P > 0.05; Gabrb3, P > 0.05). Error bars indicates SEM. **P < 0.01, ***P < 0.001 
(DRG: Control: 1.00 ± 0.01; CFA: 1.16 ± 0.05. SC: Control: 1.06 ± 0.04; CFA: 0.95 ±
0.04). No change was observed for mRNA levels of α3 (DRG: Control: 1.00 ± 0.01;
CFA: 0.93 ± 0.15. SC: Control: 1.03 ± 0.02; CFA: 0.95 ± 0.04) and β3 subunits (DRG:
Control: 1.00 ± 0.01; CFA: 0.76 ± 0.13. SC: Control: 1.04 ± 0.03; CFA: 1.01 ± 0.06). 
In summary, a raise of BDNF may influence the BDNF-TrkB signaling pathway, but no
significant change of NKCC1 mRNA was observed. The proteins responsible for GABA
production and removal were not affected by CFA injection on mRNA level in both
DRGs and spinal dorsal horn. Variations in mRNA levels of GABAA receptor subunits
were  observed after  inflammation.  However,  the  conduction of  GABAA receptors  in
DRG neurons was not significantly shifted by CFA injection, which might due to the in-
crease of α1 and α2 subunits and decrease of α5 subunits compensate each other.
4.2.4 Upregulated NKCC1 contributed to mechanical 
hypersensitivity development after peripheral 
inflammation (experiments carried by Flavia Frattini)
Although mRNA level of NKCC1 in DRGs was not altered after peripheral inflmmation,
this does not rule out that intracellular [Cl-] increase depends on the enhanced activity
of NKCC1, which is determined by the protein level of plasma membrane NKCC1. My
colleague did NKCC1 staining on DRG cryosections from intact and CFA injected mice
and quantified the fluorescence intensity on cell membrane. The result revealed that
the  CFA induced  peripheral  inflammation  significantly  upregulated  NKCC1 level  in
plasma membrane of both small and large neurons (Figure 22).  
page 49 of 98
Our previous study had shown that bumetanide, a NKCC1 inhibitor, is able to alleviate
the thermal hyperalgesia caused by nerve injury61, likely via lightening the upregulated
NKCC1 induced intracellular [Cl-] uprise. Due to the fact that the CFA injection also
leads to the increase of [Cl-] and NKCC1 in DRG neurons, we reasoned that bumetanide
probably  had  an  analgesic  effect  in  inflammatory  pain.  Mice  were  treated  with
bumetanide 2, 7, 14, and 28 days after CFA injection (Figure 23). The paw withdraw
latency upon mechanical  stimulation was significantly increased on the 2nd day and
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Figure  22:  Peripheral  inflammation upregulated cell  surface  NKCC1 level  in  DRG neurons.
NKCC1 (red) and DAPI (blue) were labeled on DRG slices from control (a) and CFA injected
mice (b). (c) the normalized fluorescence intensity of NKCC1 increased in both small and large
DRG neurons 2-day after CFA injection from 3 control and 3 CFA injected mice (small control: n
= 106; small CFA: n = 61; large control: n = 76; large CFA n= 80; small control vs small CCI,
unpaired student t-test, P < 0.01; large control vs large CCI, unpaired student t-test, P < 0.01) .
Error bars indicates SEM. **P < 0.01. Scale bars, (a, b) 20 μm (only shown in b).
even furthered on the 7th day, and the increased baseline level of withdraw latency from
the 7th day suggested a long term effect of bumetanide (Figure 23a).  Interestingly,
bumetanide treatment did not show any influence on inflammation induced thermal
hyperalgesia (Figure 23b). 
Taken together, these results indicated that the putative nociceptor NKCC1 upregula-
tion, which is likely responsible for the depolarizing shift of ECl in small diameter neu-
rons, caused by CFA injection induced inflammation specifically contributes to the de-
velopment  of  mechanical  hypersensitivity.  This  is  consistent  with  the idea  that  the
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Figure 23: Intraperitoneal administration of NKCC1 inhibitor bumetanide alleviated mechanical
but not thermal hypersensitivity caused by peripheral inflammation. Saline or bumetanide were
intraperitonealy injected in mice (CFA + Saline: n = 6; CFA + Bumetanide: n = 6) on the 2nd, 7th,
14th and 28th day after CFA injection. Both mechanical and thermal sensitivity were evaluated in
these mice.  (a)  Bumetanide injection alleviated mechanical  allodynia on the 2nd and 7th day
( Bumetanide effect was analyzed with repeated two-way analysis of variance (ANOVA) (factor
1: time; factor 2: injection): variance of sensitivity according to time (factor 1), 2nd day, p < 0.01;
7th day, p > 0.05; 14th day, p > 0.05; 28th day, p > 0.05. post-hoc Bonferroni: 2d vs 2d-1h, p <
0.05; 2d vs 2d-2h, p <0.001; 2d vs 2d-3h, p <0.001; 2d vs 2d-4h, p < 0.001; 7d vs 7d-1h, p <
0.05; 7d vs 7d-2h, p < 0.01). Although no further anti-nociceptive effect was observed on the
14th and 28th day, the baseline mechanical sensitivity was upregulated for the 7 th day after CFA
injection (repeated two-way ANOVA: variance of sensitivity according to injection (factor 2), 2nd
day, p > 0.05; 7th day, p < 0.05; 14th day, p < 0.05; 28th day, p < 0.05). (b) CFA induced thermal
hypersensitivity could not  be alleviated by bumetanide injection (repeated two-way ANOVA:
factor 1, p > 0.05 for 2nd, 7th, 14th and 28th day; factor 2, p > 0.05 for 2nd, 7th, 14th, and 28th day).
Error bars indicate SEM. *P < 0.05; **P < 0.01; ***P < 0.001.
GABAA receptors  mediated  presynaptic  control  contributes  to  the  inflammation  in-
duced mechanical hypersensitivity suggested by the behavior result of SNS-Ai38 mice
(Figure 14c).
4.3 A subpopulation of nociceptors crucial for 
presynaptic mediated mechanical allodynia in 
inflammatory pain
4.3.1 Difference between SNS-Cre and advillin-Cre
In addition to SNS-Ai38 mice, advillin-Ai38 mice were also used for 2-photon calcium
imaging to study presynaptic GABAergic control. Advillin-Ai38 mice were generated by
crossing advillin-cre mice, which express Cre recombinase in majority of sensory neu-
rons including both nociceptors and non nociceptors. Due to the fact that superficial
layer of spinal dorsal horn is only innervated by nociceptors, 2-photon calcium imaging
using spinal cords from SNS-Ai38 and advillin-Ai38 mice in this area was expected to
show accordant results. Indeed, the inhibitor effect of GABA on KCl induced calcium
transient was also observed in advillin-Ai38 mice spinal cord (Whole chamber perfu-
sion: No-change: 43 %; More Ca2+ transient: 8 %; Less Ca2+ transient: 49 %. Local per-
fusion: No-change: 41 %; More Ca2+ transient: 14 %; Less Ca2+ transient: 45 %. Figure
24c, e; 25a), and this inhibition could be abolished after nerve injury (Whole chamber
perfusion: No-change: 52 %; More Ca2+ transient: 35 %; Less Ca2+ transient: 13 %. Local
perfusion:  No-change:  67 %;  More Ca2+ transient:  27  %;  Less  Ca2+ transient:  7  %),
BDNF treatment (Whole chamber perfusion: No-change: 57 %; More Ca2+ transient: 28
%; Less Ca2+ transient: 14 %. Local perfusion: No-change: 70 %; More Ca2+ transient: 26
%; Less Ca2+ transient: 4 %) and CFA injection induced inflammation (Whole chamber
perfusion: No-change: 65 %; More Ca2+ transient: 9 %; Less Ca2+ transient: 25 %. Local
perfusion: No-change: 55 %; More Ca2+ transient: 43 %; Less Ca2+ transient: 2 %) (Fig-
ure 24; 25; 26a). And the calcium influx caused by GABA (Whole chamber perfusion:
1.7 ± 0.9 %. Local perfusion: 10.7 ± 2.3 %) was also not significantly altered by nerve in-
jury (Whole chamber perfusion: 2.1 ± 1.4 %. Local perfusion: 10.3 ± 8.3 %) and BDNF
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treatment in advillin-Ai38 spinal cord (Whole chamber perfusion: 1.6 ± 0.7 %. Local
perfusion: 18.8 ± 2.3 %) (Figure 24; 25; 26b). However, the CFA injection induced
increase of  GABA generated calcium influx observed in  SNS-Ai38 mice  spinal  cord
(Figure  17b),  suggesting  an  enhanced  excitatory  effect  of  GABA,  was  absent  in
advillin-Ai38 mice spinal cord (Whole chamber perfusion: CFA: 1.1 ± 0.4 %. Local per-
fusion: CFA: 18.7 ± 4 %. Figure 24p; 25d; 26b). Meanwhile, my colleague found that
the mechanical allodynia was only partially developed in SNS-β3-/- mice after CFA injec-
tion  (Figure 14c),  while  advillin-β3-/-  mice,  generated  by crossing advillin-Cre and
β3fl/fl mice developed mechanical allodynia to the same level as their control litter mates
(β3fl/fl)  (Figure 27).  These  difference  between  advillin-Cre  and  SNS-Cre  generated
transgenic  mice strongly  suggested the different  expression patterns  between 2 Cre
mouse lines, and this difference may be used to study the subpopulation of nociceptors
important for peripheral inflammation induced mechanical allodynia.  
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Figure 24: 2-photon images of acutely dissected spinal cord slices from advillin-Ai38
mice  (control,  CCI,  BDNF,  CFA).(a)  A  diagram  showing  expression  patter  of
GCaMP signal in advillin-Ai38 mice. 2-photon microscope imaged GCaMP3 signal
indicating [Ca2+] in Control (b - e), CCI (f – I), BDNF (j – m) CFA (n - q) spinal cord
superficial  layer in response to various stimuli.  Scale bars,  (b – q)  10 μm (only
shown in q)
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Figure  25: The  color  maps  of  2-photon  calcium
imaging of acutely dissected spinal cord slices from
advillin-Ai38  mice.  Each  color  map  represents
presynaptic  calcium  intensity  in  30  ROIs.  The
figures for control (a), CCI (b), BDNF (c) and CFA
(d)  groups  are  correlated  with  the  example  2-
photon images show in Figure 24.   
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Figure 26: The influence of GABA on presynaptic activity in acutely dissected spinal cord
slices from advillin-Ai38. The effect of GABA was examined by using 2 different application
methods,  whole  chamber  perfusion  and  local  perfusion,  which  can  influence  the
concentration of applied chemicals. (a) The inhibitory effect of 1 mM GABA on high KCl
induced Ca2+ influx was attenuated by CCI, BDNF treatment and CFA injection (Whole
chamber perfusion: Control mice n = 5; CCI mice n = 6; BDNF mice n = 3; CFA mice n = 3.
chi-squared test, Control vs CCI, P < 0.001; Control vs BDNF, P < 0.001; Control vs CFA,
P < 0.001. Local perfusion: Control mice n = 3; CCI mice n = 3; BDNF mice n = 3; CFA
mice n = 3. chi-squared test, Control vs CCI, P < 0.001; Control vs BDNF, P < 0.001;
Control vs CFA, P < 0.001.). (b) GABA induced Ca2+ transient was not influenced by CCI,
BDNF treatment or CFA injection (Whole chamber perfusion: Control  slice,  n = 4; CCI
slice, n = 5; BDNF slice, n = 6; CFA slice, n = 6. Student t-test, Control vs CCI, P > 0.05;
Control vs BDNF, P > 0.05; Control vs CFA, P > 0.05. Local perfusion: Control slice, n = 6;
CCI slice, n = 11; BDNF slice, n = 3; CFA slice, n = 6. Student t-test, Control vs CCI, P >
0.05; Control vs BDNF, P > 0.05; Control vs CFA, P > 0.05.). Error bars indicate SEM. ***P
< 0.001. 
4.3.2 Advillin-Cre is not expressed in all peptidergic 
nociceptors as SNS-Cre
SNS-Cre and advillin-Cre lines are widely used to study nociceptors and all  sensory
neurons respectively. However, N Agawal et al., who originally produced SNS-Cre mice
used in my study, showed that about 93% of small neurons in DRG are Cre positive55.
And S Zurborg et al. Suggested Cre recombinase could be found in more than 80% of
DRG neurons in advillin-Cre mouse56. Considering about 70% of DRG neurons are no-
ciceptors78, it is very possible that a subpopulation of SNS-Cre expressing nociceptors
would not express advillin, i.e. this subpopulation falls into the 20% of DRG neurons
which are advillin negative. And they might be responsible for the difference in 2-pho-
ton calcium imaging between SNS-Ai38 and advilllin-Ai38 mice, and difference in me-
chanical allodynia development between SNS-β3-/- and advillin-β3-/- mice as well.
page 57 of 98
Figure  27:  Mechanical  allodynia  induced by peripheral  inflammation developed to  similar
level in advillin-β3-/-  and β3fl/fl (β3fl/fl: n = 7; advillin-β3-/-: n = 6. Repeated two-way ANOVA (0 -
28d): factor time P < 0.0001, factor genotype P < 0.01, Bonferroni post hoc β3fl/fl vs advillin-
β3-/- on 0d, P < 0.0001. Repeated two-way ANOVA (1 – 28 day): factor time P < 0.01, factor
genotype P > 0.05) .
Nociceptors can be divided into 2 classes, peptidergic and non-peptidergic nociceptors.
Calcitonin gene-related peptide (CGRP) and isolectin B4 (IB4) are commonly used to
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Figure 28:  A big proportion of CGRP positive neurons are GCaMP3 negative in advillin-
Ai38 mice. (a) upper 2 panels showed GCaMP3 and CGRP signals in DRGs from advillin-
Ai38 and SNS-Ai38 mice. Lower 2 panels showed GCaMP3 and CGRP signals in spinal
cords from advillin-Ai38 and SNS-Ai38 mice. (b) 51% and 99% of CGRP positive DRG
neurons expressed GCaMP3 in advillin-Ai38 and SNS-Ai38 mice respectively (advillin-
Ai38, 3 mice, n = 197; SNS-Ai38, 3 mice, n = 156. Fisher’s exact test, p < 0.001). Scale
bars (a) DRG: 50 μm; SC: 100 μm.*** p < 0.0001 
mark these 2 classes respectively. DRGs and spinal cords with fluorescent calcium indi-
cator,  GCaMP,  from  SNS-Ai38  and  advillin-Ai38  animal  were  cryosectioned  and
stained with CGRP (Figure 28) and IB4  (Figure 29) to investigate the expression
patterns of corresponding Cre recombinases.  Interestingly,  Almost all  (99 %) CGRP
positive neurons carried GCaMP signal in SNS-Ai38 DRGs compare to 51 % in advillin-
Ai38 DRGs (Figure 28b), while GCaMP signal were found in virtually all IB4 positive
neurons from both SNS-Ai38 (97 %) and advillin-Ai38 DRGs (100 %) (Figure 29).
The staining on spinal cords exhibited consistent results. As expected, CGRP positive
area,  lamina I  and lamina II  out  layer,  perfectly  overlaps  the very  dorsal  region of
GCaMP signal in spinal cord from SNS-Ai38 mice (Figure 28a). However, the CGRP
staining on spinal cord from advillin-Ai38 mice reveals that the CGRP positive area has
weaker GCaMP signal compare to other GCaMP positive area (Figure 28a). IB4 stain-
ing, on the other hand, co-localized with GCaMP signal in spinal cord from both SNS-
Ai38 and advillin-Ai38 mice (Figure 29). 
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Figure  29: All IB4 positive DRG neurons expressed GCaMP3 signal in both advillin-Ai38 and
SNS-Ai38 mice.  (a)  upper 2 panels showed GCaMP3 and IB4 signals in DRGs from advillin-
Ai38 and SNS-Ai38 mice. Lower 2 panels showed GCaMP3 and CGRP signals in spinal cords
from  advillin-Ai38  and  SNS-Ai38  mice.(b)  100%  and  97%  of  IB4  positive  DRG  neurons
expressed GCaMP3 in advillin-Ai38 and SNS-Ai38 mice respectively (advillin-Ai38, 3 mice, n =
108; SNS-Ai38, 3 mice, n = 111. Fisher’s exact test, p > 0.05). Scale bars (a) DRG: 50 μm; SC:
100 μm.
In conclusion, these immunohistochemistry results revealed that there is a expression
difference  of  Cre  recombinase  in  peptidergic  nociceptors  between  SNS-Cre  and
advillin-Cre lines. This difference suggests that the excitatory effect of GABA observed
in SNS-Ai38 after inflammation was contributed by central terminals of a subpopula-
tion of peptidergic nociceptors, which does not express Cre in advillin-Cre animal. And
the fully developed mechanical allodynia of advillin-β3-/-  mice might be due to the in-
complete knockout of GABAA receptor β3 subunits in peptidergic nociceptors.
4.3.3 IB4 negative and positive putative nociceptor were similar
changed by peripheral inflammation
To further investigate the difference between peptidergic and non-peptidergic nocicep-
tors after inflammation, I labeled non-peptidergic DRG neurons with IB4 and thus sep-
arated them from peptidergic nociceptors in primary cell culture. Calcium imaging was
applied to examine their  physiological  properties.  CFA injection,  different from CCI
and BDNF incubation, successfully altered the response of small-sized DRG neurons to
GABA. The percentages of neurons displaying calcium transient were significantly in-
creased by CFA injection in small-sized neurons (IB4- Control: 17 %; IB4- CFA: 38 %;
IB4+ Control: 32 %; IB4+ CFA: 63 %. Figures 30). This result is consistent with my
observation of presynapses after inflammation and offers more evidence of excitatory
effect switch of GABA on DRG nociceptors caused by CFA injection. However, a bigger
proportion of IB4+ neurons exhibited GABA-evoked calcium transient compare to IB4-
neurons in both control and CFA groups (Figures 30). 
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The amplitude of calcium transient (R340/380 - R0) induced by high KCl in IB4- and IB4+
neurons was raised by inflammation (IB4- Control: 1.06 ± 0.07; IB4- CFA: 1.49 ± 0.07;
IB4+ Control: 1.04 ± 0.08; IB4+ CFA: 1.54 ± 0.09. Figure 31a), and co-application of
GABA could not significantly change this increase (IB4- Control:  0.85  ± 0.06; IB4-
CFA: 1.09  ± 0.07; IB4+ Control: 0.82  ± 0.07; IB4+ CFA: 1.18  ± 0.08.  Figure 31a).
However, GABA effectively decreased KCl generated calcium transient in all small di-
ameter neurons in spite of CFA injection (Figure 31b), which is different from the re-
sult of 2-photon calcium imaging on presynapses (Figure 17a, c). This may be due to
the prominent shunting effect caused by GABAA receptors activation in cell soma in
both control and CFA groups. This effect could weaken KCl induced depolarization and
in turn decrease the calcium transient. The amplitude of GABA-evoked calcium tran-
sient was only seen increased in IB4- neurons but not in IB4+ neurons after inflamma-
tion (IB4- Control: 0.06  ± 0.02; IB4- CFA: 0.13  ± 0.03; IB4+ Control: 0.07  ± 0.02;
IB4+ CFA: 0.10 ± 0.02. Figure 30b) suggesting a stronger GABA induced depolariza-
tion in IB4- putative nociceptors.
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Figure  30:  The  proportion  of  small  diameter  neurons  displaying  GABA  evoked  calcium
transient significantly increased in IB4- and IB4+ subpopulations after peripheral inflammation
(IB4- Control vs IB4- CFA, chi-squared test, P < 0.001; IB4+ Control vs IB4+ CFA, chi-squared
test, P < 0.001). The proportion of GABA activated neurons is higher in IB4+ subpopulation
despite of CFA injection (IB4- Control vs IB4+ Control, chi-squared test, P < 0.05; IB4- CFA vs
IB4+ CFA, chi-squared test, P < 0.01). Control mice, n = 4; CFA mice, n = 3. The number of
recorded neurons is on top of each bar. *P < 0.05, **P < 0.01, ***P < 0.001.
It is well-known that the intracellular calcium concentration ([Ca2+]) is crucial for vari-
ous neuronal processes including neuronal excitability, transmitter release, gene tran-
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Figure  31: GABA inhibited the high KCl triggered calcium transient in IB4- and IB4+ small
diameter neurons. (a) CFA injection caused the increase of peak value of calcium transient
(R340/380 - R0) triggered by high KCl (IB4- Control vs IB4- CFA, P < 0.001; IB4+ Control vs IB4+
CFA, P < 0.001. Student t-test) and GABA (1mM) +KCl (IB4- Control vs IB4- CFA, P < 0.01;
IB4+ Control vs IB4+ CFA, P < 0.001. Student t-test) in IB4- and IB4+ neurons. The rise of 1
mM GABA evoked calcium peak only appeared in IB4- group after inflammation (IB4- Control
vs IB4-  CFA,  P < 0.05;  IB4+ Control  vs IB4+ CFA,  P >  0.05.  Student  t-test),  and 1  μM
capsaicin evoked calcium peak was not altered by inflammation (IB4- Control vs IB4- CFA, P >
0.05; IB4+ Control vs IB4+ CFA, P > 0.05. Student t-test). (b) GABAergic inhibition on high KCl
induced calcium transient was not influenced by CFA induced inflammation in IB4- and IB4+
small diameter neurons (IB4-: Control vs CFA, P > 0.05. IB4+: Control vs CFA, P > 0.05).
Control mice, n = 4; CFA mice, n = 3. The number of recorded neurons is on top of each bar.
Error bars indicate SEM. *P < 0.05, **P < 0.01, ***P < 0.001.
scription etc79. Therefore, the homeostasis of [Ca2+] is profoundly important for proper
function of neurons. Calcium dysregulation in brain neurons had been reported in nu-
merous  pathological  conditions80.  Although  an  upregulation  of  resting  [Ca2+]  was
mostly observed in brain neurons in pathological conditions80, previous studies sug-
gested that resting [Ca2+] decreased in DRG neurons after nerve injury81. Consistently,
my results showed the resting [Ca2+] (R340/380) in CCI small diameter neurons (CCI: 0.59
± 0.03) was significantly lower than that in Control neurons (Control: 0.77  ± 0.02)
(Figure 32a).  In  addition,  CFA induced peripheral  inflammation also significantly
downregulated the resting [Ca2+] in both IB4- and IB4+ small diameter neurons (IB4-
Control: 0.83  ± 0.04; IB4- CFA: 0.72  ± 0.03; IB4+ Control: 0.24  ± 0.06; IB4+ CFA:
0.96 ± 0.04. Figure 32b). Interestingly, the resting [Ca2+] of IB4- neurons was lower
than that of IB4+ neurons in both control and CFA injected groups (Figure 32b). No-
ticeably, BDNF treatment increased the resting [Ca2+] rather than decreasing it (BDNF:
0.89 ± 0.03. Figure 32a) despite it could mimic the effect of CCI on both cellular and
behavior levels61.   
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Figure 32: The resting [Ca2+] in small diameter DRG neurons was influenced by nerve injury,
BDNF and peripheral inflammation. (a) The resting [Ca2+] was downregulated in small diameter
neurons from CCI mice (Control vs CCI, student t-test, P < 0.001). BDNF treatment elevated
the resting [Ca2+] in small diameter neurons (Control vs BDNF, student t-test, P < 0.001). (b)
The resting [Ca2+]  was downregulated in  IB4-  and IB4+ small  diameter  neurons from CFA
injected mice (IB4-: Control vs CFA, P < 0.05. IB4+: Control vs CFA, P < 0.001. Student t-test).
The  resting  [Ca2+]  in  IB4+  neurons  is  higher  than  IB4-  neurons  despite  of  CFA  injection
(Control: IB4- vs IB4+, P < 0.001. CFA: IB4- vs IB4+, P < 0.001. Student t-test). Control mice, n
= 4; CFA mice, n = 3. The number of recorded cells is on top of each bar. Error bars indicate
SEM. *P < 0.05, **P < 0.01, ***P < 0.001. 
In general, these calcium imaging data showed dramatic changes of small sized DRG
neurons after inflammation, and it suggested there is a considerable variation between
IB4- and IB4+ neurons. GABA exhibited a more excitatory effect after inflammation,
which is consistent with 2-photon imaging data from spinal cords of SNS-Ai38 mice.
However, whether the differences between SNS-cre and advillin-cre generated trans-
genic mice in 2-photon calcium imaging (SNS-Ai38 and advillin-Ai38) and behavior
tests (SNS-β3-/- and advillin-β3-/-) are due to the different Cre expression in peptidergic
neurons cannot be concluded yet. First, IB4- and IB4+ neurons were generally changed
towards the same direction by inflammation; Second, cultured DRG neurons may offer
valuable information, but the recordings on somas may also provide different results
compare to recordings on central terminals. Therefore, further approach with clear la-
beling of peptidergic and/or non-peptidergic central terminals is required to answer
this question.
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5 Discussion
5.1 GABAergic presynaptic control in 
neuropathic pain
5.1.1 Intracellular [Cl-] and presynaptic GABAergic inhibition
The principle  inhibitory  effect  of  GABA is  mediated by the activation of  ionotropic
GABAA receptors which increase membrane permeability to chloride. Thus the intracel-
lular [Cl-] is critical for a proper functioning GABAergic inhibition. The cation chloride
cotransporters, such as inwardly directed NKCCs and outwardly directed KCCs, play a
major role in maintaining intracellular [Cl-]. In CNS, highly expressed KCC2 keeps low
intracellular [Cl-] in mature neurons34, so the activation of GABAA receptors generates
an inward flow of Cl- and hyperpolarizes the neurons.  Mature DRG neurons, unlike
CNS neurons, do not extrude chloride ions to the level lower than extracellular space
due maintain a relatively high intracellular [Cl-]34 compare to CNS neurons due to the
predominantly expressed NKCC1 and low or absent expression of KCC2, and the rever-
sal  potential  of  Chloride  is  more  positive  than  membrane  potential.  Therefore,  the
mechanism of GABAergic inhibition on DRG neurons is different from that on CNS
neurons. The opening of ionotropic GABAA receptors permits an outflow of Cl- and de-
polarized the DRG neurons, which is named as PAD (primary afferent depolarization)
when this happens on central terminals. PAD rather inhibits transmitter release than
facilitates it. Two explanations had been proposed for its inhibitory effect: suppressing
the transmitter release by inactivating the voltage gated calcium channels; hampering
the action potential by either inactivating the voltage gated sodium channels or shunt-
ing effect, or both of them. It is reasonable to speculate that the stronger PAD may fail
the inhibition based on these proposed mechanisms, and it may even be converted to
excitation and activate the transmitter release when itself could directly evoke action
potentials.
Previous studies have suggested an increase of intracellular [Cl-] in DRG neurons after
nerve injury by showing the increased activity of NKCC1 and a depolarizing shift  of
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Ecl61,74,82–84. My chloride imaging on Clomeleon mice DRGs and my colleague’s perfo-
rated patch clamp results confirmed the rise of intracellular [Cl-] in both small and
large DRG neurons on ex vivo level 2 days after nerve injury. And it seems like this in-
crease is not strong enough for GABA to switch its role from inhibitory to excitatory,
since the proportion of neurons displaying GABA-evoked calcium transient was not
changed by nerve injury. Takkala et al., by using computer simulations and dynamic
clamp experiments, provided evidence that the depolarizing shift of ECl and increased
intrinsic excitability were both necessary for PAD-induced spiking85. Therefore, the rea-
son that no change of GABA-evoked calcium transient was observed after nerve injury
may because that the intrinsic excitability of DRG neurons probably was not affected.
Besides, the reduced GGABA may also limit the depolarization caused by GABA. Never-
theless, all these evidences about elevated [Cl-] in pathological conditions were acquired
from neuron soma studies; whether the [Cl-] increases in central terminals after nerve
injury and therefore enhances PAD was still unclear. 
5.1.2 Nerve injury elevates presynaptic [Cl-] and abolishes 
GABAergic presynaptic inhibition 
The 2-photon calcium imaging on central terminals of nociceptors was employed to in-
vestigate the effect of GABA on presynapses. Acute spinal cord slices were prepared
from  advillin-Ai38  and  SNS-Ai38  mice,  where  calcium  indicator  GCaMP3  was  ex-
pressed in advillin-Cre positive (sensory neurons) and SNS-Cre positive (nociceptors)
cells respectively. The recordings on superficial layers demonstrated that GABA-evoked
calcium transient  in  nociceptor  central  terminals  was  not  affected  by  nerve  injury,
which  is  consistent  with  result  acquired  from  cultured  neurons.  However,  GABA
showed presynaptic inhibitory effect by suppressing the high KCl induced calcium tran-
sient in these presynaptic terminals, and nerve injury could disrupt such presynaptic
inhibition.  These  evidence  suggest  that  nerve  injury  abolishes  the  GABA  mediated
presynaptic  inhibition rather than converts  it  to  excitation.  This  disinhibition effect
may be due to the combine effect of upregulated intracellular [Cl-] and reduced GGABA 61.
The latter one probably restrains the increased strength of PAD. Since the intrinsic ex-
citability of DRG neurons is essential for PAD-induced spikes, it probably not affected
in central terminals after nerve injury. Yet, further study is required to address this. My
colleagues also discovered that the NKCC1 inhibitor bumetanide effectively alleviated
nerve injury induced thermal hypergesia while did not show any influence on mechani-
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cal allodynia suggesting presynaptic chloride concentration is crucial for thermal hy-
peragesia in neuropathic61.  Interestingly, the efficacy of bumetanide decreased along
time: strong on 2nd day after injury, weak on 14th day after injury, and no analgesic ef-
fect on 21st day after injury. This time dependent effect is consistent with the depolariz-
ingly shifted ECl 2-day post nerve injury, which further indicates that the lost of presy-
naptic inhibition caused by intracellular chloride elevation contributes to thermal hy-
peragesia in the early stage of neuropathic pain.
To clarify the function of presynaptic inhibition in vivo, our group tried to generate no-
ciceptor specific GABAA receptor deficient mice.  Every GABAA receptor is assembled
from 5 subunits. α and γ subunits form the BZD binding site at their interface, and α
and β subunits form the binding site for GABA20. Mutation of α and γ subunits was re-
ported that only affect bensodiazepine sensitivity without changing the response to GA-
BA69,86. On the other hand, β subunits are only responsible for GABA but not BZD bind-
ing effect, and β3 subunit-containing GABAA receptors selectively mediate the action of
intravenous general anesthetics87.  Moreover, β3 subunits, the most dominant β sub-
units expressed by DRG neurons88,89, are widely expressed in spinal cord and DRG sug-
gesting a possible role in presynaptic inhibition90,91. Therefore, β3 subunits were chosen
to knock out in nociceptors by crossing SNS-Cre to floxed β3 mice to create SNS-β3 -/-
mice61.  The SNS-β3-/- mice showed hypersensitivity to both mechanical  and thermal
stimulations compare to their control litter mates. Moreover, nerve injury could further
develop their mechanical sensitivity but not the thermal sensitivity. These observations
indicated  presynaptic  inhibition  contributes  to  modulation  of  both  mechanical  and
thermal nociceptive signal, especially the latter one, which is almost solely controlled
by presynaptic inhibition.
5.1.3 BDNF-TrkB signaling regulates nerve injury induced lost 
of GABAergic presynaptic inhibition
BDNF-TrkB signaling is crucially involved in regulating the survival and differentiation
of  neuronal  populations  during  development  stage,  and plays  an  important  role  in
modulating synaptic  transmission  and plasticity  in  CNS in  adult  stage92,93.  Previous
studies had indicated BDNF-TrkB signaling could decrease GABAergic  inhibition by
rising intracellular [Cl-] through down-regulation of KCC294,95. When intracellular [Cl-]
is elevated, the activation of GABAA  receptors will generated less or no hyperpolariza-
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tion, i.e. less or no inhibition. The group of De Koninck reported that the inverted post-
synaptic inhibition on nociceptive signal transmission after nerve injury was due to the
same mechanism, and the source of BDNF is ATP activated microglias51. Although DRG
neurons barely express KCC2, previous studies suggested BDNF-TrkB signaling might
also modulate intracellular [Cl-] via regulating NKCC1, which is heavily expressed by
sensory neurons35–38,70,71.  Indeed, my colleague observed a depolarizing shift of Ecl in
BDNF treated DRG neurons, which is similar to the Ecl of neurons from nerve injury
animal61. In addition, the depolarizing shift of Ecl was successfully reversed by BDNF
scavenger TrkB-Fc61. Consistently, disinhibition effect of GABA observed in nerve in-
jury group also appeared in BDNF treatment group in 2-photon calcium imaging. To-
gether, these results suggested the presynaptic inhibition caused by nerve injury is reg-
ulated by BDNF-TrkB signaling. 
5.2 GABAergic presynaptic control in 
inflammatory pain
5.2.1 The GABAergic presynaptic control in inflammatory pain 
is different from the one in neuropathic pain
A declined inhibitory control in spinal cord dorsal horn after peripheral inflammation
had been addressed by several reviews13,28. It is widely agreed that the hypersensitivity
caused by inflammation is  due to the diminished glycinergic inhibition proposed by
Zeilhofer’s group: the peripheral inflammation increases the expression of cyclooxyge-
nase-2 (COX-2), in turn, leads to the release of pronociceptive and proinflammatory
prostaglandin E2 (PGE2) in spinal cord; The PGE2 binds to neuronal EP2 receptors ex-
pressed by interneurons, and decreases the glycinergic inhibitory control on these neu-
rons via a protein kinase A (PKA) dependent phosphorylation of the glycine receptor 3
(GlyR3) subtype of strychnine-sensitive glycine receptors96. Nevertheless, this well-es-
tablished mechanism only covers postsynaptic control, because there is no evidence in-
dicating glycine plays any role in PAD or presynaptic inhibition97–100, and glycine recep-
tors are not expressed by nociceptors101. 
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Besides the different postsynaptic  disinhibition mechanisms, the behavior results of
GABAergic studies also set the inflammatory pain apart from neuropathic pain. We had
previously reviewed that most studies showed GABAA receptor agonists still exhibited
analgesic effect in neuropathic pain condition, while their effect is controversial in in-
flammatory pain: both agonists and antagonists of GABAA receptor had been suggested
to regulate analgesia77. This ambiguous effect of GABAergic pathway may be attributed
to a special event - DRR, which is only observed after inflammation but not after nerve
injury52. DRR had been well reviewed by Willis52. Briefly, DRR is generated by an in-
tense form of PAD capable of triggering action potential. At this moment, PAD rather
performs an excitatory effect instead of inhibition. Therefore, the balance of postsynap-
tic GABAergic inhibition and presynaptic GABAergic excitation caused by intensified
PAD might decide whether GABA holds an analgesic effect after peripheral inflamma-
tion. It had been proposed that action potentials of nociceptive fibers could be presy-
napticlly evoked by non-nociceptive activated Aβ fibers through GABAergic interneu-
rons, and this action potential would travel both retrogradely and anterogradely to in-
duce neurogenic inflammation by DRR and contribute to hypersensitivity respective-
ly43,77,102,103. 
5.2.2 Peripheral inflammation induces the GABAergic 
presynaptic disinhibition and excitation
A possible cause of the vigorous PAD after inflammation, similar to presynaptic disinhi-
bition in neuropathic pain, is the increase of intracellular [Cl-] regulated by NKCC177. In
fact, CFA injection could induce a depolarizing shift of ECl without changing the GGABA in
nociceptors. The presynaptic disinhibition effect of GABA was also observed in spinal
dorsal horn superficial layers by using 2-photon calcium imaging. In addition, the acti-
vation of GABAA receptors even generated presynaptic calcium transient in a bigger
proportion of ROIs, which suggests a switch to excitatory effect of GABA. Considering
that  the activity of  NKCC1 can be upregulated by inflammation53,82,  and NKCC1 in-
hibitor, bumetanide, is able to abolish DRR, the increase of intracellular [Cl-] possibly
depends on NKCC1104. Although the mRNA level of NKCC1 was not changed by periph-
eral inflammation, an upregulation of NKCC1 expression on membrane was observed in
both small and large DRG neurons. Interestingly, the depolarizing shift of ECl was only
observed in small neurons. The mechanism underlying this is still unknown. An intra-
cellular [Cl-] related negative feedback system to regulate the activity of NKCC1 had
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been suggested by previous study39. It is possible that this feedback system was still in-
tact in large neurons after CFA injection. Further study on this feedback system and its
possible change in various pathological conditions would be helpful to understand the
role of NKCC1 in pathological pain. On behavior level, the NKCC1 inhibitor bumetanide
was found to reduce mechanical sensitivity developed by CFA injection without affect-
ing the thermal hypersensitivity, and this treatment exhibited a long term effect. No-
ticeably,  bumetanide  only  alleviated  thermal  hyperalgesia  in  our  neuropathic  pain
model61. Both mechanical and thermal sensitivity of SNS-β3-/- mice could be furthered
by CFA injection suggesting that presynaptic element only partially contributes to me-
chanical and thermal hypersensitivity induced by CFA injection.  
In addition to intracellular [Cl-],  the effect of GABA also depends on the release of
GABA and the density of GABAA receptors. The first one can be regulated by GABA cat-
alyzing enzymes, GAD65 and GAD67, and the GABA remover GAT1. The mRNA level of
three were unchanged neither in DRG nor in spinal cord after inflammation. α and β
GABAA receptor subunits form binding sites for GABA. Five of them were found ex-
pressed in DRG neurons77.  α1 subunits were reported to have low expression level in
superficial layer and rather concentrate in lamina III19,21. The upregulation of α1 mRNA
implies an increase of this subunit in non-nociceptor terminals. GABAA receptors con-
taining α2 subunits  are predominantly expressed by C fibers21, and had been reported
to be crucial for spinal anti-hyperalgesic effects of BZD105 in inflammatory and neuro-
pathic pain. Here I showed significant decrease of α2 subunits mRNA in both DRG and
spinal cord dorsal horn samples. It’s likely that there was a downregulation of α2 sub-
units on both presynaptic and postsynaptic sides, though further study, such as in situ
hybridization and immunohistochemistry, should be employed to confirm this. A re-
duction of KCC2 had been observed in spinal cord after peripheral inflammation as well
as after nerve injury. This implies a similar postsynaptic disinhibition happens in neu-
ropathic pain.  And the downregulation of α2 subunits in postsynaptic  neurons may
weaken the BZD induced analgesic effect. If the α2 subunits are decreased in primary
afferent central terminals, the effect of BZD is also lessened, which may decrease the
strength of PAD. Interestingly, an increase of α5 subunits mRNA was also observed but
only  in  DRG.  α5 subunits  are  mainly  expressed  by  extrasynaptic  GABAA receptors,
which generate a tonic conductance and produce a shunt affecting excitability and gain
control106–110. CNS studies, especially on hippocampus, strongly indicated GABAA recep-
tors containing α5 subunits play a critical role in the regulation of plasticity which is
important for learning and memory109,111.  Recently,  Perez-Sanchez et al.  showed that
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these receptors in spinal cord also contributed to a tonic current. In spite of no hyper-
sensitivity was observed in mice lacking α5 subunits, these mice had a prolonged recov-
ery from inflammatory and neuropathic pain, and increased response in the late phase
of the formalin test112. These results imply that α5 subunits are important for central
sensitization and synapse plasticity. However, the contributions from presynaptic and
postsynaptic sides remain to be determined. The mRNA level of β3 subunits was not in-
fluenced by CFA injection induced inflammation. But the inflammation may change β3
subunits in another way. There is evidence that PGE2, which is released in spinal cord
after inflammation, is able to increase cAMP level in DRG neurons as well as in spinal
neurons96,113, which is able to subsequently upregulate PKA mediated protein phospho-
rylation. And McDonald et al. showed that the phosphorylation of β3 subunits could
enhance the activity of GABAA receptors114. Together, these results imply that the re-
lease of PGE2 boosts GABAA receptors containing β3 subunits via PKA mediated phos-
phorylation in presynaptic and postsynaptic neurons. Factors described above imply
that the slightly increased GGABA after inflammation may be due to the balance of down-
regulation of α2 subunits and enhanced activity of β3 subunits containing receptors.      
In conclusion, the NKCC1-dependent increase of intracellular [Cl-] causes the malfunc-
tion of presynaptic inhibition in inflammatory pain as well as in neuropathic pain. Al-
though this presynaptic malfunction contributes to both mechanical and thermal hy-
persensitivity in neuropathic and inflammatory pain, its role is more prominent in ther-
mal hyperalgesia induced by nerve injury and in mechanical allodynia generated by in-
flammation. The later one is likely due to the excitatory switch of GABA effect, which is
caused by enhanced PAD strong enough to trigger action potentials. 
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5.3 A subpopulation of peptidergic nociceptors 
is essential for inflammation induced mechanical 
allodynia
5.3.1 Difference between SNS-Cre and advillin-Cre generated 
transgenic mice 
Nociceptors can be classified based on conduction velocities (caused by different level
of  myelination),  innervation  patterns,  specificity  to  various  sensory  modalities,  and
molecular  markers.  And  these  various  classifications  also  correlated,  for  example,
TRPV1 positive and Mrgprd positive nociceptors mediate noxious thermal and mechan-
ical stimuli respectively115,116. Nerve injury and peripheral inflammation not only disturb
spinal circuit controlling nociceptive signal transmission, but can also cause sensitiza-
tion of DRG neurons which is attributable to hypersensitivity117–119.  Study on TRPV1-/-
mice revealed that these transgenic mice did not develop heat hyperalgesia after CFA
injection,  but  nerve injury  successfully  generated  heat  hyperalgesia  in  them117.  This
finding  suggests  that  the  population  of  neurons  sensitized  by different  pathological
conditions are different. Here, my 2-photon calcium imaging results provide evidence
supporting this idea by showing that primary afferent central terminals in advillin-Ai38
and SNS-Ai38 mice had similar change after nerve injury, disinhibition effect of GABA
was observed in both of them, yet the excitatory effect of GABA generated by peripheral
inflammation was only seen in SNS-Ai38 spinal cord slices. Consistent with this, the
difference between advillin-β3-/- and SNS-β3-/- in behavior test was also observed: me-
chanical  and thermal  sensitivities  were  both further  developed by CFA injection  in
these two transgenic mouse lines, but SNS-β3-/- did not fully develop the mechanical al-
lodynia. 
5.3.2 Different expression patterns of SNS-Cre and advillin-Cre 
in nociceptors
Zurborg et al., who generated advillin-Cre mice, reported that the Cre recombinase was
expressed in 82.28% or 87.74% of all-sized sensory neurons depends on different inves-
tigation methods56. On the other hand, Cre recombinase was reported to be expressed
in 93% of small sensory neurons in SNS-Cre transgenic mice55. Therefore, the possible
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explanation of the different results between advillin-Cre and SNS-Cre generated trans-
genic mice is the different Cre expression patterns in nociceptors from there two mouse
lines. Indeed, I found almost all (99%) CGRP positive DRG neurons from SNS-Ai38
mice expressed GCaMP3, and half (49%) of CGRP positive neurons from advillin-Ai38
mice did not express GCaMP3. Yet, virtually all IB4 positive DRG neurons from adillin-
Ai38 (100%) and SNS-Ai38 (97%) mice are  GCaMP3 positive.  These immunohisto-
chemistry results indicates that the Cre expression driven by the regulatory elements of
advillin gene is absent in a big proportion of peptidergic nociceptors. 
Together with presynaptic calcium imaging and behavior study from advillin-Cre and
SNS-Cre generated mice, these immunochemistry results imply that the peptidergic no-
ciceptors, at least part of them, are responsible for the presynaptic excitatory effect of
GABA and mechanical allodynia in inflammatory pain. This is strongly supported by
the observation of Brenneis et al.119. They found that the silencing of TRPV1 receptors,
which are mainly expressed in peptidergic neurons12, only abolished mechanical hyper-
sensitivity developed by peripheral inflammation but not by nerve injury.  
5.3.3 Comparison between peptidergic and non-peptidergic 
nociceptors
Further investigation of peptidergic  and non-peptidergic  nociceptors  was carried on
cultured DRG neurons thanks to IB4 labeling of alive neurons. The calcium imaging re-
sults revealed that  the peptidergic  and non-peptidergic small diameter neurons had
similar changes after peripheral inflammation. The proportion responding to GABA ap-
plication was increased in both peptidergic and non-peptidergic neurons. This is only
partially consistent with the result of the 2-photon calcium imaging on spinal cords,
since  the difference  between advillin-Ai38 and SNS-Ai38 mice  implied that  the  in-
creased of GABA triggered calcium transient in nociceptor central terminals was mainly
contributed by peptidergic nociceptors. One possible explanation for this controversy
between calcium imaging on cultured neurons and central terminals is that the expres-
sion pattern of GABAA receptors in the somas of cultured neurons is different from cen-
tral terminals. The GABA induced depolarization may be enhanced in both peptidergic
and non-peptidergic nociceptor central terminals after inflammation, likely due to in-
tracellular [Cl-] increase and the change of GABAA receptor expression, but it is only
strong enough to trigger calcium transient in former ones, which is supported by the re-
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sult showing the amplitude of GABA-evoked calcium transient was only upregulated in
IB4- neurons after inflammation. In primary neuron culture, the GABA generated de-
polarization could be more intensive in neuron somas due to  the higher density of
GABAA receptors, and triggered calcium transient in non-peptidergic neurons as well.
The increased amplitude of calcium transient caused by high KCl, with and without
GABA, suggested an upregulated sensitivity of all putative nociceptors after inflamma-
tion. This probably is contributed by the upregulated activity of voltage gated sodium
channels120 and the lowered resting [Ca2+], which built up a larger driven force for Ca2+
influx. Noticeably, GABA suppressed high KCl triggered calcium influx in majority of
putative nociceptors from both intact and CFA injected mice. This may be due to the
more intense shunting effect of GABA in somas than central terminals. 
Although peptidergic and non-peptidergic neurons were similarly modulated after in-
flammation, the discrepancy between these 2 subpopulations should not be neglected.
In cell culture, GABA triggered calcium transient in more IB4+ neurons than in IB4-
neurons regardless of CFA injection. The resting [Ca2+] of IB4- neurons is lower than
that of IB4+ neurons. However, whether these differences are consistent in central ter-
minals, and the functional difference underlain by them remains to be investigated. 
5.3.4 Calcium homeostasis in pathological condition
Homeostasis of [Ca2+] is crucial for neurons to function properly, because [Ca2+] influ-
ences action potential transportation and transmitter release, and Ca2+ is also an 2nd
messenger in various signaling pathways79. The rise of neuronal [Ca2+] is usually initi-
ated by action potential, which opens voltage gated calcium channels, and generates a
Ca2+ influx which can then trigger the release of endoplasmic reticulum (ER) and mito-
chondrion stored Ca2+ via signaling pathway. The excessive Ca2+ can be purged away to
extracellular  space  or  organelles  by  various  Ca2+ pumps  and  exchangers,  such  as
Na+/Ca2+ exchanger (NCX) and plasma membrane Ca2+-ATPase (PMCA) in cell mem-
brane, sarcoendoplasmic reticulum Ca2+-ATPase (SERCA) in ER membrane and Ca2+
uni-porter  (CUP) in  mitochondrion membrane (reviewed by Gleichmann and Matt-
son121 and Zündorf and Reiser80).
It had been reported that nerve injury rather decreased the resting intracellular [Ca2+]
of DRG neurons than increases it122, which is often observed in brain neurons in patho-
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logical conditions80. My calcium imaging result indicats that not only nerve injury but
peripheral  inflammation  also  reduces  the  intracellular  [Ca2+]  of  DRG  nociceptors.
Gemes et at. indicated that the upregulated activity of PMCA leads to the reduction of
resting Ca2+ level in axotomized sensory neurons. Compare to the elevated PMCA, the
activity of SERCA responsible for returning Ca2+ to ER decreased after injury123, which
can disturb the role of ER as a calcium sink. CUP and other calcium transporters on mi-
tochondrion have not been investigated in DRG neurons. The important role of mito-
chondrion in calcium homeostasis is to sequester excess Ca2+ during the development
of calcium transient124. Interruption of presynaptic mitochondrial Ca2+ uptake may sig-
nificantly influence the recovery from high [Ca2+] and the transmitter release. The al-
tered dynamic control of [Ca2+] due to the changed resting [Ca2+] and modulated Ca2+
transporters  can  also  influence  the  calcium-sensitive  signaling  pathways  regulating
gene  expression  and  enzyme  activity.  Nevertheless,  the  activities  of  all  these  Ca2+
pumps and exchangers in DRG neurons and their contributions to the homeostasis of
Ca2+ remain to be examined in pathological conditions. 
Noticeably, there was a rise of resting [Ca2+] level in BDNF treated DRG neurons which
is consistent with previous study indicating BDNF elevates intracellular [Ca2+]125. Al-
though  BDNF  is  released  in  spinal  dorsal  horn  after  nerve  injury  and  inflamma-
tion51,126,127, the resting [Ca2+] was rather lowered in DRG neurons. These phenomena
suggest a spatial specific effect of BDNF, which is limited in central terminals of DRG
neurons, and the [Ca2+] change in neural soma is possibly regulated by other factors. 
5.4 Brief summary
5.4.1 Summary of results
In present study I explored the character of GABAergic presynaptic control for nocicep-
tive signal transmission in spinal dorsal horn in physiological and pathological condi-
tions. I found GABAergic presynaptic disinhibition in neuropathic and inflammatory
pain animal models. The disinhibition after nerve injury, which most likely mediated by
spinal BDNF, is essential for thermal hyperagesia. In inflammatory pain model, in ad-
dition to disinhibition, GABA also acquired more excitatory effect on central terminals
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of CGRP positive neurons (peptidergic nociceptors), which leaded to mechanical allo-
dynia.
Half  a  century  ago,  Melzack  and Wall  proposed the  classic  GCT which describes  a
spinal circuit where the dorsal horn inhibitory interneurons occupy the key position
and regulate the nociceptive signal transmission from PNS to CNS. Nowadays, the im-
proved GCT suggests this regulation is employed by both presynaptic and postsynaptic
inhibition. GABA is the major inhibitory neurotransmitter in the nervous system, and
GABAA receptors had been found to express on both central terminals of primary affer-
ents and spinal neurons21. Pharmacological studies with GABA and its antagonists pro-
vided huge body of evidence indicating GABAergic inhibition has an analgesic effect.
However,  the contribution of pre- inhibition to this analgesic effect had never been
clearly addressed separately. 
Previously, most direct recording for presynaptic inhibition study on cellular level were
carried on cultured DRG neurons. Recently, Zeilhofer’s group tried to study the genuine
presynaptic control by generating a conditional nociceptor-specific GABAA receptor α2
subunit deficient mouse line (SNS-α2-/-)69. It was reported that DZP lost its potentiating
effect on PAD and a major part of its spinal anti-hyperalgesic action against inflamma-
tory hyperalgesia in these mice. However, This SNS-α2-/-  mouse line exhibited normal
GABAA receptor currents, and behavior to mechanical and thermal stimulation, and de-
veloped neuropathic and inflammatory pain sensitization as wild type animal. These
characters of SNS-α2-/- mice make it an excellent tool to study the effect of positive al-
losteric modulator on presynaptic GABAA receptors, but the contribution of GABAA re-
ceptors mediated PAD in physiological and various pathological conditions kept un-
solved. 
Here in addition to investigation on neuron somas in cell culture and acutely dissected
whole mount DRG, I managed to selectively record presynaptic activity by specifically
express GCaMP3 in sensory neurons. All-sensory neuron- and nociceptor-specific GECI
mice (advillin-Ai38 and SNS-Ai38) were generated by crossing two different Cre mouse
lines, advillin-Cre56 and SNS-Cre55, to Ai38 mice carrying a floxed STOP cassette pre-
venting GCaMP3 expression. Recording on these slices, for the first time, provided ex
vivo evidence for GABAergic inhibition on presynapses, and its change after nerve in-
jury and inflammation. These results together with the work of my colleagues, for the
first time, confirmed the contribution of presynaptic inhibition on nociceptive signal
regulation. We discovered that nerve injury and peripheral inflmmation could disturb
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GABAergic presynaptic inhibition, mainly due to the upregulation of intracellular [Cl-]
and change of GGABA, and leaded to the lost of GABAergic presynaptic inhibition and the
GABAergic  presynaptic  excitation  respectively  (Figure  33).  These  malfunctioning
presynaptic inputs contributed to neuropathic and inflammatory pain differently. Fur-
ther more, The difference between advillin-Cre and SNS-Cre generated transgenic mice
and study with non-peptidergic marker, IB4, further indicated that the malfunction of
GABAergic presynaptic inhibition on peptidergic and non-peptidergic nociceptors con-
tributed to the hypersensitivity responding to different modality inputs. These new un-
derstandings suggest, from a presynaptic point of view, neuropathic and inflammatory
pain should be treated accordingly. Furthermore, modality specific pain treatment in
various condition can focus on specific subpopulation.
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Figure  33:  Hypothetical  scheme showing the presynaptic  control  on nociceptors  in  different
conditions. High threshold nociceptors are activated by nociceptive stimuli and transmit action
potentials  to  their  central  terminals  innervating  postsynaptic  projection  neurons  which  can
transport the nociceptive signals to brain. Both the presynaptic central terminals of nociceptors
and  postsynaptic  projection  neurons  are  regulated  by  GABAergic  inhibitory  interneurons
receiving  input  from  non-peptidergic  sensory  neurons.  (a)  In  pathological  condition,  the
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activation of non-nociceptive sensory neurons can suppress the nociceptive signal, i.e., close
the gate of pain, by inhibiting the presynaptic central terminals. This presynaptic inhibition is
disturbed in pathological conditions. (b) After nerve injury, the presynaptic [Cl-] is upregulated by
a BDNF-TrkB signaling activated pathway. This [Cl-] alteration ceases the presynaptic inhibition
mediated by GABAA receptors. In other words, presynaptic GABA losses its ability to close the
gate of pain, and nociceptive stimuli generates stronger pain. (c) The peripheral inflammation
also  elevates  [Cl-]  in  presynaptic  nociceptors.  However,  GGABA is  not  diminished  as  in
neuropathic  pain  condition.  This  probably  further  enhances the  GABAA receptors  mediated
depolarization,  which  is  strong  enough  to  trigger  action  potentials  in  nociceptor  central
terminals.  This  action potential  anterogradely  activates  postsynaptic  projection  neurons and
retrogradely facilitates peripheral inflammation. In this case, the gate of pain is opened, and low
threshold stimuli could generate pain which is termed as allodynia.
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